Hypotrichosis 4

Mendelian MONDO:0100522 Pathograph 12 Show in embeddings browser Hair Disorder Congenital Hypotrichosis

Hypotrichosis 4 (HYPT4; OMIM 146550), clinically known as Marie Unna hereditary hypotrichosis 1 (MUHH1), is a rare autosomal dominant hair disorder with a characteristic triphasic course: scalp hair, eyebrows and eyelashes are absent or scanty at birth, coarse and wiry hair grows in during childhood, and progressive scalp hair loss begins around puberty. Other ectodermal structures are essentially spared. The molecular lesion is unusual and is easy to state backwards. The disease variants do not lie in the coding sequence of the hairless gene (HR) at 8p21.3. They lie in HRURF (approved 2020; historically and still widely called U2HR), a small inhibitory upstream open reading frame embedded in the 5' untranslated region of the HR transcript, which encodes a conserved 34-amino-acid peptide and normally represses translation of the downstream main HR ORF. Loss-of-initiation, delayed-termination, nonsense and missense variants all abolish that repression, and functional assays show they converge on *increased* translation of the main HR ORF. The consequence for hairless is therefore overproduction of an otherwise wild-type corepressor - a dosage/gain-of-expression lesion - not loss of hairless function. This distinguishes HYPT4 sharply from the biallelic HR coding loss-of-function disorders (atrichia with papular lesions, alopecia universalis congenita), which are separate entities and are not curated here. What excess hairless then does to the follicle is established only in the mouse. The ENU-derived hairpoor mouse carries the orthologous uORF start-codon mutation, and in that model HR overexpression alters Wnt-pathway modulators and shortens the hair cycle. Those downstream steps have not been demonstrated in human MUHH1 scalp, and the two published mouse results point in opposite directions on Wnt activity; both points are recorded in `discussions`.

Ask OpenScientist

Ask a research question about Hypotrichosis 4. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Mappings
1
Inheritance
7
Pathophys.
2
Histopath.
9
Phenotypes
3
Gaps
12
Pathograph
2
Genes
2
Medical Actions
4
Differentials
1
Models
2
References
1
Deep Research
🏷

Classifications

Harrison's Part
DERMATOLOGY GENETICS ENVIRONMENT DISEASE
🔗

Mappings

MONDO
MONDO:0018631 Marie Unna hereditary hypotrichosis Not Yet Curated
skos:broadMatch MONDO
MONDO:0018631 is the parent grouping concept "Marie Unna hereditary hypotrichosis". It has exactly two children in MONDO - MONDO:0100522 (hypotrichosis 4 / MUHH1, causal gene HGNC:55085 HRURF) and MONDO:0013017 (hypotrichosis 5 / MUHH2, attributed to EPS8L3). Because the parent spans two different causal loci it is a broader concept than this entry, not an exact match, and is recorded as a cross-reference only.
👪

Inheritance

1
Autosomal dominant HP:0000006
Heterozygous HRURF (U2HR) variants segregate with the phenotype in multigenerational families across several ancestries, including the original 1925 German kindred. Sporadic (presumed de novo) cases are also reported. Penetrance and expressivity are left unset: no formal penetrance study was found, and although reports describe severity varying within families, no source was located that assesses expressivity as such.
Autosomal dominant inheritance
Show evidence (3 references)
PMID:20659777 SUPPORT Human Clinical
"MUHH is an autosomal dominant disorder that is characterized by the absence or scarcity of scalp hair, eyebrows, and eyelashes at birth; coarse and wiry hair during childhood; and progressive hair loss beginning around puberty."
States the autosomal dominant inheritance pattern of MUHH alongside its defining clinical course.
PMID:26269244 SUPPORT Human Clinical
"Both these mutations cosegregated with the disease phenotype in the two families."
Cosegregation of heterozygous U2HR variants with the phenotype in two multigenerational families supports dominant transmission.
PMID:37012647 SUPPORT Human Clinical
"We report a sporadic case of a 4-year-old boy with clinical features suggestive of MUHH, in whom we identified the new pathogenic variant c.67C>T; p.(Gln23*) in U2HR."
Documents a sporadic presentation, so a negative family history does not exclude the diagnosis.
?

Discussions and Knowledge Gaps

3
Does hairless overexpression in MUHH1 raise or lower net Wnt/beta-catenin activity in the hair follicle?
CONTROVERSY OPEN muhh1_wnt_direction
Both published answers come from the same group working in the same hairpoor mouse, and they point in opposite directions. In 2010 they reported that HR overexpression decreases Sfrp2, a secreted Wnt inhibitor, and concluded that alopecia follows from abnormal upregulation of Wnt signaling. In 2014 they reported that HR overexpression increases Dkk1, also a secreted Wnt inhibitor and a catagen inducer, and concluded that Dkk1 upregulation drives the follicular abnormality. Increasing one Wnt inhibitor while decreasing another does not yield a single net direction, and no study measures a direct Wnt/beta-catenin pathway output such as nuclear beta-catenin or Axin2/Lef1 transcription in the mutant follicle. Until such a readout exists the pathway node is curated as DYSREGULATED rather than INCREASED, and any downstream reasoning that assumes "excess Wnt" in MUHH1 is running ahead of the data.
Show evidence (2 references)
PMID:19897589 SUPPORT Model Organism
"This mutation conferred overexpression of HR through translational derepression and, in turn, decreased the expression of Sfrp2, an inhibitor of the Wnt signaling pathway."
The result read as increased Wnt activity - one side of the discrepancy.
PMID:24447645 SUPPORT Model Organism
"Dkk1 expression was increased in the skin of (+)/Hr(HP) and Hr(Hp)/Hr(Hp) mice, as well as in Hr-overexpressing mouse keratinocytes."
The result pointing the other way - a second Wnt inhibitor going up rather than down.
Does anything downstream of increased HR translation - Wnt modulator change, premature catagen, follicle shortening - actually occur in human MUHH1 scalp?
HUMAN MODEL MISMATCH OPEN muhh1_human_mechanism_gap
The human evidence stops early. Increased translation of the main HR ORF is shown in human reporter assays, and reduced follicle density is shown in human scalp biopsy. Everything in between - the Wnt modulator changes, earlier catagen entry, and follicle shortening - comes from the hairpoor mouse alone, and that model is semidominant with a homozygous phenotype (complete baldness, cystic follicles) that has no human counterpart. The largest human histopathological study states outright that the mechanism of progressive hair loss is unknown, and no transcriptomic, proteomic or single-cell dataset from MUHH1 follicles was found. So the entry's middle nodes are model-derived and should be read that way. The resolving experiments would be a scalp-biopsy hair-cycle and Wnt-target readout in genotyped MUHH1 patients, and a heterozygous knock-in of a human HRURF variant.
Show evidence (2 references)
PMID:10674378 SUPPORT Human Clinical
"The mechanism of progressive hair loss is unknown."
The human histopathological study explicitly leaves the follicle-loss mechanism open, which is the gap this discussion records.
PMID:19513791 SUPPORT Model Organism
"These mice display sparse and short hair in the Hr(Hp)/+ heterozygous state and complete baldness in the Hr(Hp)/Hr(Hp) homozygous state."
Shows the model's semidominant behaviour, the specific respect in which it diverges from the human heterozygous-only disease.
Should MUHH1 variants be attributed to HRURF as a gene, or to a regulatory element of HR?
OPEN QUESTION OPEN muhh1_gene_symbol_attribution
Every primary report from 2009 to 2023 describes the lesion as being in "U2HR, an inhibitory upstream open reading frame in the 5' UTR of the human hairless gene" - that is, as a regulatory element of HR, not as a separate gene. HGNC approved HRURF as its own protein-coding gene record only in 2020, and reports from 2025 onward use that symbol while glossing it as "formerly U2HR". MONDO records HGNC:55085 as the causal gene for MONDO:0100522, and this entry follows that. The open question is practical rather than nomenclatural: variant-calling pipelines and gene panels built around HR coding exons do not report this element, which is why the causal variant escaped detection for nine years after the locus was mapped, and a panel that lists "HR" is not necessarily testing HRURF.
Show evidence (2 references)
PMID:19122663 SUPPORT Human Clinical
"In a large Chinese family carrying MUHH, we identified a pathogenic initiation codon mutation in U2HR, an inhibitory upstream ORF in the 5' UTR of the gene encoding the human hairless homolog (HR)."
The founding paper describes the element as a uORF within HR's 5' UTR, using the U2HR name.
PMID:40433810 SUPPORT Human Clinical
"A novel likely pathogenic variant c.105G>T (p.(*35Tyrext*?)) in HRURF, formerly known as U2HR, causing MUHH1 was identified."
A recent report using the approved HRURF symbol and stating explicitly that it is the former U2HR, confirming the two names denote one element.
⚙

Pathophysiology

7
HRURF Upstream Open Reading Frame Disruption
A heterozygous germline variant disrupts the 34-codon inhibitory upstream open reading frame HRURF (U2HR) in the 5' untranslated region of the HR transcript. Loss-of-initiation, delayed-termination, nonsense and missense changes all destroy the uORF peptide's normal function. The variant is loss-of-function *for the uORF*; its effect on hairless is the opposite (see the next node).
Genetic context HRURF hgnc:55085 HUGO Gene Nomenclature Committee (hgnc) Relation: this genetic context concerns this gene This genetic context concerns HRURF (hgnc:55085). hgnc:55085 is a gene from the HUGO Gene Nomenclature Committee. variant_origin: GERMLINE zygosity: HETEROZYGOUS functional_impact_category: LOSS_OF_FUNCTION
The category applies to HRURF, whose repressive uORF function is abolished. The downstream consequence for HR is increased protein output, which is a different claim about a different gene product and is modeled as a separate node.
uORF-mediated repression of translational initiation at the main HR ORF GO:0045947 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves uORF-mediated repression of translational initiation at the main HR ORF, annotated with negative regulation of translational initiation (GO:0045947), qualified as loss of function. GO:0045947 is a biological process from the Gene Ontology. ⇓ LOSS OF FUNCTION
Show evidence (3 references)
PMID:19122663 SUPPORT Human Clinical
"In 18 more families from different ancestral groups, we identified a range of defects in U2HR, including loss of initiation, delayed termination codon and nonsense and missense mutations."
Defines the classes of uORF-disrupting variants that constitute the initiating lesion.
PMID:19122663 SUPPORT Computational
"U2HR is predicted to encode a 34-amino acid peptide that is highly conserved among mammals."
The uORF peptide length and its mammalian conservation are a sequence prediction, not an experimental measurement, and are graded accordingly.
PMID:20163456 SUPPORT Human Clinical
"Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript were found as the cause for autosomal dominant Marie Unna hereditary hypotrichosis."
Independently states that the causal lesion is loss of function of the inhibitory uORF, not of the hairless coding sequence.
Translational De-repression of the Main HR Open Reading Frame
With the inhibitory uORF disabled, ribosomes translate the downstream main HR open reading frame more efficiently. This is the pivotal direction in the entry: translation of HR goes *up*, not down.
translation of the main HR open reading frame GO:0006412 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased translation of the main HR open reading frame, annotated with translation (GO:0006412). GO:0006412 is a biological process from the Gene Ontology. ↑ INCREASED
Show evidence (2 references)
PMID:19122663 SUPPORT In Vitro
"Functional analysis showed that these classes of mutations all resulted in increased translation of the main HR physiological ORF."
Directly states the increased-translation direction for every reported class of uORF variant.
PMID:20163456 SUPPORT In Vitro
"Functional assays confirmed that this mutation led to increased translation of the main HR ORF."
An independent laboratory reproduces the increased-translation result for a further missense uORF variant.
Hairless Corepressor Protein Overexpression
Hairless is a nuclear-receptor transcriptional corepressor expressed mainly in skin and brain that governs hair-follicle morphogenesis and cycling. In MUHH1 the protein itself is structurally normal; there is simply too much of it. Because HR acts by repressing transcription, excess HR means excess corepression at its target genes. Hair growth depends on HR being present in the right amount rather than merely present, which is why both loss and gain of HR produce alopecia.
hair follicle keratinocyte CL:2000092 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves hair follicle keratinocyte, annotated with hair follicular keratinocyte (CL:2000092). CL:2000092 is a cell type from the Cell Ontology.
hairless-mediated transcriptional corepression at nuclear-receptor target genes GO:0000122 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased hairless-mediated transcriptional corepression at nuclear-receptor target genes, annotated with negative regulation of transcription by RNA polymerase II (GO:0000122). GO:0000122 is a biological process from the Gene Ontology. ↑ INCREASED
Show evidence (3 references)
PMID:24447645 SUPPORT Model Organism
"Hairless (Hr), a transcriptional corepressor expressed mainly in the skin, regulates hair follicle (HF) morphogenesis and hair cycling."
Establishes what the overproduced protein does - transcriptional corepression governing follicle morphogenesis and cycling.
PMID:19122663 SUPPORT In Vitro
"show that fine-tuning of HR protein levels is important in control of hair growth"
States that the quantity of HR protein, not its presence or absence, is the controlled variable in hair growth - the dosage framing of this node.
PMID:19897589 SUPPORT Model Organism
"This study indicates that the gain in function of HR also results in alopecia, as seen with the loss of function of HR, via abnormal upregulation of the Wnt signaling pathway."
States that gain, not loss, of HR causes the alopecia in this model - the direction this entry curates.
Dysregulated Wnt Pathway Modulation in the Hair Follicle
In the hairpoor mouse, HR overexpression changes the expression of secreted Wnt inhibitors in follicular skin. The two published results are not concordant in sign: Sfrp2 falls (which the authors read as excess Wnt activation), while Dkk1 rises (a Wnt inhibitor and catagen inducer). The node therefore records the pathway as dysregulated rather than asserting a direction, and the discrepancy is tracked as an open controversy. Nothing here has been shown in human MUHH1 skin.
Wnt signaling pathway modulation in follicular skin GO:0016055 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated Wnt signaling pathway modulation in follicular skin, annotated with Wnt signaling pathway (GO:0016055). GO:0016055 is a biological process from the Gene Ontology. ↕ DYSREGULATED secreted Wnt-inhibitor (Sfrp2, Dkk1) expression GO:0030178 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated secreted Wnt-inhibitor (Sfrp2, Dkk1) expression, annotated with negative regulation of Wnt signaling pathway (GO:0030178). GO:0030178 is a biological process from the Gene Ontology. ↕ DYSREGULATED
Show evidence (2 references)
PMID:19897589 SUPPORT Model Organism
"This study indicates that the gain in function of HR also results in alopecia, as seen with the loss of function of HR, via abnormal upregulation of the Wnt signaling pathway."
Reports abnormal upregulation of Wnt signaling downstream of HR gain in the hairpoor mouse.
PMID:24447645 SUPPORT Model Organism
"One of the Wnt inhibitors, Dickkopf (Dkk), inhibits hair growth during the hair cycle as a catagen inducer of apoptosis, resulting in HF reductions."
Establishes Dkk1's role as a Wnt inhibitor and catagen inducer, the axis the same group found upregulated by HR - the reason this node is labelled dysregulated rather than uniformly activated.
Premature Catagen Entry and Hair Follicle Shortening
Heterozygous hairpoor mice enter catagen earlier and grow shorter hair follicles than wild type. This is the mechanistic proposal for why MUHH1 hair is short and why follicles progressively fail; it is a mouse result and has not been shown in human MUHH1 scalp.
hair cycle (anagen-catagen transition) GO:0042633 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal hair cycle (anagen-catagen transition), annotated with hair cycle (GO:0042633). GO:0042633 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Show evidence (1 reference)
PMID:24447645 SUPPORT Model Organism
"Additionally, an earlier entrance of HFs into catagen and shortened HF length in (+)/Hr(HP) mice compared to wild-type mice was observed."
Directly measures earlier catagen entry and shortened follicles in the heterozygous model of MUHH1.
Progressive Loss of Hair Follicle Density
Scalp biopsy in MUHH1 shows a markedly reduced number of follicles per unit area with only a mild to moderate inflammatory infiltrate, little fibrosis and no scarring - a non-scarring alopecia. The mechanism by which follicles are lost was explicitly stated as unknown in the largest histopathological pedigree study and remains so.
hair follicle keratinocyte CL:2000092 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves hair follicle keratinocyte, annotated with hair follicular keratinocyte (CL:2000092). CL:2000092 is a cell type from the Cell Ontology.
hair follicle development and maintenance GO:0001942 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal hair follicle development and maintenance, annotated with hair follicle development (GO:0001942). GO:0001942 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Show evidence (3 references)
PMID:10674378 SUPPORT Human Clinical
"Histologically, there are dramatically reduced numbers of follicles per unit area, averaging nine total hairs per 4 mm cross-section as compared with a normal of 40."
Quantifies the loss of follicle density in affected human scalp.
PMID:10674378 SUPPORT Human Clinical
"The mechanism of progressive hair loss is unknown."
The authors state directly that the mechanism of follicle loss was not established, which is why this node carries no asserted cellular mechanism.
PMID:39872230 SUPPORT Human Clinical
"Genetic factors, altered hair shaft morphology, a decreased number of functional follicles, and abnormal follicle cycling have been suggested as contributors to the disease pathogenesis, with mutations in the U2HR gene, located on chromosome 8p21, identified as the underlying cause."
A recent molecularly confirmed case series names reduced functional follicle number and abnormal follicle cycling as the proposed contributors, matching this node and the one above it.
Abnormal Hair Shaft Formation
The hair that does grow is structurally abnormal: shafts of uniformly increased and variable diameter (up to 0.12 mm), deeply pigmented, twisted, bent at odd angles, longitudinally grooved on scanning electron microscopy, and irregular in cross-section. Dermoscopy shows pili torti. This produces the coarse, wiry, unruly hair of the childhood phase.
Show evidence (2 references)
PMID:10674378 SUPPORT Human Clinical
"Individual hair shafts are deeply pigmented, variable in diameter, twisted, and bent at odd angles; some have a longitudinal groove visible on scanning electron microscopy."
Structural characterization of the abnormal shaft by light and scanning electron microscopy.
PMID:10674378 SUPPORT Human Clinical
"The hair shafts are uniformly increased in diameter, measuring up to 0.12 mm."
Quantifies the increased shaft calibre that gives the hair its coarse quality.
✶

Histopathology

2
Reduced Follicular Density on Scalp Biopsy
Horizontal sections show a dramatic reduction in the number of follicles per unit area - about nine total hairs per 4 mm cross-section against a normal of 40.
Show evidence (1 reference)
PMID:10674378 SUPPORT Human Clinical
"Histologically, there are dramatically reduced numbers of follicles per unit area, averaging nine total hairs per 4 mm cross-section as compared with a normal of 40."
The quantitative histopathological finding on scalp biopsy.
Mild Inflammatory Infiltrate Without Scarring
A mild to moderate inflammatory infiltrate is present, but there is little fibrosis and no scarring - MUHH1 is a non-scarring alopecia, which separates it from the cicatricial alopecias.
Show evidence (1 reference)
PMID:10674378 SUPPORT Human Clinical
"A mild to moderate inflammatory infiltrate is present, but little fibrosis and no scarring."
Establishes the non-scarring character of the alopecia and the presence of only a modest infiltrate.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Hypotrichosis 4 Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

9
Head and Neck 4
Sparse Scalp Hair at Birth HP:0002209 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sparse scalp hair (HP:0002209). HP:0002209 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:20659777 SUPPORT Human Clinical
"MUHH is an autosomal dominant disorder that is characterized by the absence or scarcity of scalp hair, eyebrows, and eyelashes at birth; coarse and wiry hair during childhood; and progressive hair loss beginning around puberty."
Defines absent or scanty scalp hair at birth as a characteristic feature.
PMID:10674378 REFUTE Human Clinical
"Affected individuals are born with adequate, normal to coarse hair."
In this large pedigree the neonatal hair was adequate rather than sparse, contradicting the claim that sparse hair at birth is universal.
Sparse Eyebrows HP:0045075 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sparse eyebrow (HP:0045075). HP:0045075 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:10674378 SUPPORT Human Clinical
"All affected individuals have sparse to absent eyebrows, eyelashes and body hair including secondary sexual hair."
Reports sparse to absent eyebrows in all affected members of a 16-affected pedigree.
PMID:20814945 SUPPORT Human Clinical
"We concluded that there may be considerable clinical variations in MUHH, and that eyebrow loss is an important clue for accurate diagnosis."
A U2HR-confirmed Turkish family in which eyebrow loss was the diagnostic clue.
Sparse Eyelashes HP:0000653 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sparse eyelashes (HP:0000653). HP:0000653 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10674378 SUPPORT Human Clinical
"All affected individuals have sparse to absent eyebrows, eyelashes and body hair including secondary sexual hair."
Reports sparse to absent eyelashes in all affected individuals of the pedigree.
Widely Spaced Upper Incisors FREQUENT Widely-spaced incisors HP:0006304 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Widely-spaced incisors (HP:0006304). HP:0006304 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10674378 SUPPORT Human Clinical
"Other ectodermal structures are unaffected except for exceptionally widely spaced upper incisor teeth seen in 50% of affected individuals."
Reports widely spaced upper incisors in 50% of affected individuals, supporting both the finding and its FREQUENT band, while confirming that other ectodermal structures are spared.
Integument 5
Coarse Wiry Scalp Hair in Childhood Coarse hair HP:0002208 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Coarse hair (HP:0002208). HP:0002208 is a phenotype from the Human Phenotype Ontology.
Sequelae: Progressive Scalp Hair Loss After Puberty
Show evidence (2 references)
PMID:10674378 SUPPORT Human Clinical
"During early infancy the scalp hair becomes more coarse and wiry and stands out from the head."
Direct clinical description of the coarse, wiry childhood hair.
PMID:26269244 SUPPORT Human Clinical
"Marie Unna hereditary hypotrichosis (MUHH) is a rare autosomal dominant genodermatosis characterized by coarse, wiry, twisted hair developing during early childhood, with subsequent progressive hair loss."
Confirms coarse, wiry, twisted childhood hair as the defining feature in molecularly confirmed families.
Progressive Scalp Hair Loss After Puberty Progressive alopecia HP:0002287 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Progressive alopecia (HP:0002287). HP:0002287 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:10674378 SUPPORT Human Clinical
"In some individuals, scalp hair is progressively lost beginning at puberty or beyond, until only a sparse fringe in the tonsorial distribution remains."
Describes the post-pubertal progressive, patterned scalp hair loss and its endpoint.
PMID:39872230 SUPPORT Human Clinical
"The study describes two cases from different unrelated families presenting with recalcitrant alopecia resembling female pattern hair loss, with dermoscopic findings consistent with pili torti and yellow dots."
Documents that the adult hair loss can present as, and be mistaken for, female pattern hair loss.
Sparse Body Hair HP:0002231 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sparse body hair (HP:0002231). HP:0002231 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10674378 SUPPORT Human Clinical
"All affected individuals have sparse to absent eyebrows, eyelashes and body hair including secondary sexual hair."
Documents sparse to absent body hair including secondary sexual hair.
Pili Torti HP:0003777 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pili torti (HP:0003777). HP:0003777 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39872230 SUPPORT Human Clinical
"The study describes two cases from different unrelated families presenting with recalcitrant alopecia resembling female pattern hair loss, with dermoscopic findings consistent with pili torti and yellow dots."
First published dermoscopic description of MUHH, in patients with a confirmed HRURF variant.
Abnormal Hair Shaft Morphology HP:0003328 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abnormal hairshaft morphology (HP:0003328). HP:0003328 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:10674378 SUPPORT Human Clinical
"Cross-sectional shapes are variable and irregular, exhibiting oval, angular to reniform shapes."
Documents the irregular hair-shaft cross-sectional morphology.
🧬

Genetic Associations

2
HRURF
Gene: HRURF hgnc:55085 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is HRURF (hgnc:55085). hgnc:55085 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (3 references)
PMID:19122663 SUPPORT Human Clinical
"In a large Chinese family carrying MUHH, we identified a pathogenic initiation codon mutation in U2HR, an inhibitory upstream ORF in the 5' UTR of the gene encoding the human hairless homolog (HR)."
The founding report identifying U2HR/HRURF as the causal element and locating it in the 5' UTR of HR.
PMID:19122663 SUPPORT Human Clinical
"In 18 more families from different ancestral groups, we identified a range of defects in U2HR, including loss of initiation, delayed termination codon and nonsense and missense mutations."
Establishes the allelic spectrum within the uORF across 18 additional unrelated families.
PMID:39872230 SUPPORT Human Clinical
"Genetic testing confirmed a heterozygous pathogenic variant in the HRURF gene, associated with autosomal dominant Marie Unna Hereditary Hypotrichosis."
A recent report using the approved HRURF symbol for the same causal element, confirming heterozygous variants in patients.
HR
Gene: HR hgnc:5172 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is HR (hgnc:5172). hgnc:5172 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: DISPUTED variant_origin: GERMLINE
💊

Medical Actions

2
Genetic Counseling and Supportive Hair Care
Action: genetic counselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is genetic counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. Ontology label: Genetic Counseling NCIT:C15240
Platform: Behavioral / lifestyle
There is no disease-modifying therapy. Management is genetic counseling for the 50% transmission risk of a dominant trait, molecular confirmation of the family variant, and cosmetic/supportive measures (gentle hair care, camouflage, wigs). This entry states that plainly rather than listing aspirational options.
Show evidence (1 reference)
PMID:24898506 SUPPORT Human Clinical
"Therapy does not exist for these rare forms of alopecia. However, molecular genetic diagnosis is possible for the identification of the genetic causes and for the specification of the recurrence risk."
States both halves of current management - no therapy exists, and molecular diagnosis serves recurrence-risk counseling.
Topical Minoxidil
Action: topical pharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is topical pharmacotherapy, annotated with Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. Ontology label: Pharmacotherapy NCIT:C15986
Agent: minoxidil CHEBI:6942 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses minoxidil (CHEBI:6942). CHEBI:6942 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Small molecule
A single 2025 case report describes significant hair regrowth on once-daily 5% topical minoxidil in a child with a recurrent HRURF variant. This is one patient and is not established therapy for MUHH1; it is recorded so the lead is discoverable, not as a recommendation.
🔬

Diagnosis

2
HRURF (U2HR) Sequencing
Diagnosis is confirmed by sequencing the small HRURF/U2HR upstream open reading frame in the 5' UTR of HR. This is a clinically important pitfall: the element is non-coding with respect to HR, so an HR coding-exon panel, or an exome pipeline that does not annotate this UTR-embedded ORF, will miss the causal variant. That is exactly why linkage mapped MUHH to 8p21 in 2000 but the causal element was not found until 2009.
HRURF (U2HR) sequencing NCIT:C19770 NCI Thesaurus (NCIT)
Markers: Heterozygous pathogenic variant within the 34-codon HRURF (U2HR) upstream open reading frame in the 5' UTR of HR at 8p21.3.
Results: A heterozygous loss-of-initiation, delayed-termination, nonsense or missense HRURF variant in a patient with the characteristic hair phenotype confirms MUHH1.
Show evidence (3 references)
PMID:19122663 SUPPORT Human Clinical
"In a large Chinese family carrying MUHH, we identified a pathogenic initiation codon mutation in U2HR, an inhibitory upstream ORF in the 5' UTR of the gene encoding the human hairless homolog (HR)."
Identifies the region that must be sequenced to make the molecular diagnosis.
PMID:20659777 SUPPORT Human Clinical
"Direct sequencing of U2HR was performed."
Direct sequencing of the U2HR element is the method used to make the molecular diagnosis in practice.
PMID:30809827 SUPPORT Human Clinical
"We found that the c.1A>G mutation in an inhibitory upstream open-reading frame of HR (U2HR) was present in all MUHH patients"
Sanger sequencing of the U2HR element identified the causal variant in every affected family member.
Trichoscopy and Hair Shaft Microscopy
Clinical diagnosis rests on the triphasic history plus examination of the hair itself. Trichoscopy shows pili torti and yellow dots; light microscopy and scanning electron microscopy of plucked shafts show increased and variable diameter, twisting, angular bending, longitudinal grooving and irregular cross-sections. These findings support the diagnosis but are not specific enough to replace HRURF sequencing.
trichoscopy and hair shaft microscopy NCIT:C124351 NCI Thesaurus (NCIT)
Markers: Pili torti and yellow dots on trichoscopy; twisted, longitudinally grooved hair shafts of increased and variable diameter on microscopy.
Show evidence (2 references)
PMID:39872230 SUPPORT Human Clinical
"The study describes two cases from different unrelated families presenting with recalcitrant alopecia resembling female pattern hair loss, with dermoscopic findings consistent with pili torti and yellow dots."
Provides the dermoscopic (trichoscopic) findings used to support the diagnosis.
PMID:10674378 SUPPORT Human Clinical
"Individual hair shafts are deeply pigmented, variable in diameter, twisted, and bent at odd angles; some have a longitudinal groove visible on scanning electron microscopy."
Describes what hair-shaft light and scanning electron microscopy show in this disease.
📈

Progression

3
Congenital and infantile
Scalp hair, eyebrows and eyelashes are absent or scanty at birth in most reported families, although one large pedigree described normal to coarse neonatal hair.
Show evidence (1 reference)
PMID:40433810 SUPPORT Human Clinical
"Marie Unna hereditary hypotrichosis 1 (MUHH1) is a rare autosomal dominant condition characterized by the absence or scarcity of hair at birth with the growth of coarse, wiry, and unruly hair during childhood and progressive hair loss after puberty."
States the congenital phase of the natural history in a recent HRURF-confirmed family.
Childhood
Coarse, wiry, unruly hair grows in and stands out from the head. Hair shafts are thick, twisted, grooved and irregular in cross-section.
Show evidence (1 reference)
PMID:10674378 SUPPORT Human Clinical
"During early infancy the scalp hair becomes more coarse and wiry and stands out from the head."
Describes the childhood phase of the natural history.
Post-pubertal
Progressive patterned scalp hair loss begins around puberty and continues into adulthood, in some individuals leaving only a tonsorial fringe. At least one family member has been reported with the opposite course - progressive scalp hair growth during adulthood - so the post-pubertal trajectory is not uniform.
Show evidence (2 references)
PMID:10674378 SUPPORT Human Clinical
"In some individuals, scalp hair is progressively lost beginning at puberty or beyond, until only a sparse fringe in the tonsorial distribution remains."
Describes the post-pubertal progressive loss and its most advanced endpoint.
PMID:40433810 SUPPORT Human Clinical
"This case report describes the clinical presentation of three Danish family members with congenital hypotrichosis with a new phenotypic variation marked by progressive scalp hair growth during adulthood in one of the members."
Documents a family member whose adult course was hair growth rather than loss, supporting the statement that the post-pubertal trajectory is not uniform.
📊

Prevalence

1
Worldwide
Unknown Rare
No numeric prevalence or incidence estimate for HYPT4/MUHH1 was found. Sources describe the disease only qualitatively as rare; the measure they intend is not stated, so `measure_type` is UNKNOWN and no rate is recorded. Orphanet does index the parent concept Marie Unna hereditary hypotrichosis as ORPHA:444, but that code is not present in the Orphadata leaf-disorder bulk file this repository caches, so no ORPHA-quoted epidemiology row could be curated.
Show evidence (1 reference)
PMID:26269244 SUPPORT Human Clinical
"Marie Unna hereditary hypotrichosis (MUHH) is a rare autosomal dominant genodermatosis characterized by coarse, wiry, twisted hair developing during early childhood, with subsequent progressive hair loss."
Characterizes the disease as rare, which is the only occurrence claim the literature supports.
🔀

Differential Diagnoses

4

Conditions with similar clinical presentations that must be differentiated from Hypotrichosis 4:

Atrichia with papular lesions / alopecia universalis congenita
Overlapping Features Caused by biallelic loss-of-function variants in the HR *coding* sequence - the opposite direction of HR dysfunction from MUHH1, and recessive rather than dominant. Presents as complete, permanent alopecia from infancy with papular lesions, without the coarse-wiry childhood phase. Conflating these entities with MUHH1 because both involve HR is the main naming hazard around this locus.
Distinguishing Features
  • Autosomal recessive rather than dominant
  • Biallelic loss-of-function variants in the HR coding sequence, not in the HRURF uORF
  • Total irreversible alopecia from infancy with papular lesions
  • No coarse, wiry childhood hair phase
Show evidence (1 reference)
PMID:24898506 SUPPORT Human Clinical
"the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna"
A clinical review separating the causal genes of the isolated alopecias, listing the HR gene for atrichia congenita and U2HR for Marie Unna type hypotrichosis as distinct entries.
Hypotrichosis 5 (MUHH2) Not Yet Curated MONDO:0013017
Overlapping Features The sibling MONDO concept under the same parent grouping. Exome sequencing in a single four-generation Chinese family mapped to 1p21.1-1q21.3 identified a heterozygous EPS8L3 missense variant. It is phenotypically overlapping but genetically distinct, and is a separate disease entry, not a subtype of HYPT4. Support rests on one family; subsequent MUHH cohorts have not replicated it.
Distinguishing Features
  • Maps to 1p21.1-1q21.3 rather than to 8p21.3
  • Attributed to EPS8L3 rather than to HRURF
  • No HRURF/U2HR variant identified in the reported family
Show evidence (1 reference)
PMID:23099647 SUPPORT Human Clinical
"We identified a missense mutation in EPS8L3 (NM_024526.3: exon2: c.22G->A:p.Ala8Thr) within 1p21.1-1q21.3."
Identifies a different gene at a different locus in a family with a MUHH phenotype, establishing the entity as genetically distinct from HYPT4.
Autosomal recessive woolly hair / hypotrichosis
Overlapping Features Biallelic LIPH or LPAR6 variants disrupt the LIPH-LPA-LPAR6 axis, giving tightly curled woolly hair with hypotrichosis from birth. Recessive, and the hair is kinky/woolly rather than the coarse wiry hair of MUHH1.
Distinguishing Features
  • Autosomal recessive, frequently in consanguineous families
  • Tightly curled woolly hair from birth
  • No triphasic sparse-then-coarse-then-lost natural history
Show evidence (1 reference)
PMID:24898506 SUPPORT Human Clinical
"the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna"
Places LIPH and LPAR6 in the recessive hypotrichosis group, distinct from the U2HR-related Marie Unna type.
Androgenetic / female pattern hair loss
Overlapping Features The adult MUHH1 phenotype can closely mimic patterned hair loss and has been misdiagnosed as recalcitrant female pattern hair loss. The congenital and childhood phases, sparse eyebrows and eyelashes, and abnormal hair shafts distinguish it.
Distinguishing Features
  • No congenital sparse-hair phase and no coarse, wiry childhood hair
  • Eyebrows, eyelashes and body hair are normal
  • Hair shafts are structurally normal on microscopy
Show evidence (1 reference)
PMID:39872230 SUPPORT Human Clinical
"The study describes two cases from different unrelated families presenting with recalcitrant alopecia resembling female pattern hair loss, with dermoscopic findings consistent with pili torti and yellow dots."
Documents MUHH1 presenting as, and being mistaken for, recalcitrant female pattern hair loss.
🐁

Animal Models

1
Hairpoor mouse (Hr^Hp) Genetic
An ENU-derived mouse carrying the mutation orthologous to human MUHH1 variants - in the start codon of the second uORF in the Hr 5' UTR. It is the only in vivo model of the uORF-dosage mechanism, and every downstream mechanistic claim in this entry beyond "translation of HR increases" comes from it.
Species
Mouse
Genotype
Hr^Hp/+ heterozygous and Hr^Hp/Hr^Hp homozygous; T-to-A transversion at nucleotide 403 abolishing the uATG of the second uORF in the Hr 5' UTR
Genes
Hr hgnc:5172 HUGO Gene Nomenclature Committee (hgnc) Relation: this experimental model concerns this gene This experimental model concerns Hr (hgnc:5172). hgnc:5172 is a gene from the HUGO Gene Nomenclature Committee.
Publication
Show evidence (1 reference)
PMID:19513791 SUPPORT Model Organism
"Both mutations were in the uATG codon of the second uORF in the 5' UTR and corresponded to the mutations identified in Marie Unna Hereditary Hypotrichosis (MUHH) patients."
Establishes that the mouse lesion is at the same uORF start codon as the human MUHH variants, which is what makes the model mechanism-matched.
{ }

Source YAML

click to show
name: Hypotrichosis 4
creation_date: "2026-09-07T00:00:00Z"
category: Mendelian
description: >
  Hypotrichosis 4 (HYPT4; OMIM 146550), clinically known as Marie Unna hereditary
  hypotrichosis 1 (MUHH1), is a rare autosomal dominant hair disorder with a
  characteristic triphasic course: scalp hair, eyebrows and eyelashes are absent or
  scanty at birth, coarse and wiry hair grows in during childhood, and progressive
  scalp hair loss begins around puberty. Other ectodermal structures are essentially
  spared.

  The molecular lesion is unusual and is easy to state backwards. The disease variants
  do not lie in the coding sequence of the hairless gene (HR) at 8p21.3. They lie in
  HRURF (approved 2020; historically and still widely called U2HR), a small inhibitory
  upstream open reading frame embedded in the 5' untranslated region of the HR
  transcript, which encodes a conserved 34-amino-acid peptide and normally represses
  translation of the downstream main HR ORF. Loss-of-initiation, delayed-termination,
  nonsense and missense variants all abolish that repression, and functional assays
  show they converge on *increased* translation of the main HR ORF. The consequence for
  hairless is therefore overproduction of an otherwise wild-type corepressor - a
  dosage/gain-of-expression lesion - not loss of hairless function. This distinguishes
  HYPT4 sharply from the biallelic HR coding loss-of-function disorders (atrichia with
  papular lesions, alopecia universalis congenita), which are separate entities and are
  not curated here.

  What excess hairless then does to the follicle is established only in the mouse. The
  ENU-derived hairpoor mouse carries the orthologous uORF start-codon mutation, and in
  that model HR overexpression alters Wnt-pathway modulators and shortens the hair
  cycle. Those downstream steps have not been demonstrated in human MUHH1 scalp, and
  the two published mouse results point in opposite directions on Wnt activity; both
  points are recorded in `discussions`.
disease_term:
  preferred_term: hypotrichosis 4
  term:
    id: MONDO:0100522
    label: hypotrichosis 4
synonyms:
- MUHH1
- Marie Unna hereditary hypotrichosis 1
- Marie Unna congenital hypotrichosis
- hypotrichosis, Marie Unna type, 1
- HYPT4
parents:
- Hair Disorder
- Congenital Hypotrichosis
references:
- reference: DOI:10.1111/jocd.70382
  title: "Significant Hair Regrowth With 5% Topical Minoxidil in a Child With Marie Unna Hereditary Hypotrichosis Caused by a Recurrent <scp><i>HRURF</i></scp> Variant"
- reference: PMID:22584530
  title: "A newly identified missense mutation of the HR gene is associated with a novel, unusual phenotype of Marie Unna Hereditary Hypotrichosis 1 including limb deformities."
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0018631
      label: Marie Unna hereditary hypotrichosis
    mapping_predicate: skos:broadMatch
    mapping_source: MONDO
    mapping_justification: >
      MONDO:0018631 is the parent grouping concept "Marie Unna hereditary
      hypotrichosis". It has exactly two children in MONDO - MONDO:0100522
      (hypotrichosis 4 / MUHH1, causal gene HGNC:55085 HRURF) and MONDO:0013017
      (hypotrichosis 5 / MUHH2, attributed to EPS8L3). Because the parent spans two
      different causal loci it is a broader concept than this entry, not an exact
      match, and is recorded as a cross-reference only.
classifications:
  harrisons_chapter:
  - classification_value: DERMATOLOGY
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
inheritance:
- name: Autosomal dominant
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  description: >
    Heterozygous HRURF (U2HR) variants segregate with the phenotype in
    multigenerational families across several ancestries, including the original
    1925 German kindred. Sporadic (presumed de novo) cases are also reported.
    Penetrance and expressivity are left unset: no formal penetrance study was
    found, and although reports describe severity varying within families, no
    source was located that assesses expressivity as such.
  evidence:
  - reference: PMID:20659777
    reference_title: "Marie Unna hereditary hypotrichosis: identification of a U2HR mutation in the family from the original 1925 report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "MUHH is an autosomal dominant disorder that is characterized by the absence or scarcity of scalp hair, eyebrows, and eyelashes at birth; coarse and wiry hair during childhood; and progressive hair loss beginning around puberty."
    explanation: States the autosomal dominant inheritance pattern of MUHH alongside its defining clinical course.
  - reference: PMID:26269244
    reference_title: "Identification of mutations in U2HR in two Chinese families with Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Both these mutations cosegregated with the disease phenotype in the two families."
    explanation: Cosegregation of heterozygous U2HR variants with the phenotype in two multigenerational families supports dominant transmission.
  - reference: PMID:37012647
    reference_title: "Identification of a novel sporadic U2HR pathogenic variant in a patient with Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We report a sporadic case of a 4-year-old boy with clinical features suggestive of MUHH, in whom we identified the new pathogenic variant c.67C>T; p.(Gln23*) in U2HR."
    explanation: Documents a sporadic presentation, so a negative family history does not exclude the diagnosis.
genetic:
- name: HRURF
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  gene_term:
    preferred_term: HRURF
    term:
      id: hgnc:55085
      label: HRURF
  notes: >
    HRURF (HGNC:55085, "HR upstream open reading frame", 8p21.3) was approved as a
    distinct HGNC gene record only in 2020, with U2HR retained as an alias. Every
    primary MUHH1 report from 2009 through at least 2023 attributes the variants to
    "U2HR", described as an inhibitory upstream ORF inside the 5' UTR of HR
    (HGNC:5172); reports from 2025 onward use HRURF and gloss it as "formerly known
    as U2HR". The two names denote the same element. MONDO records HRURF as the
    RO:0004003 causal gene for MONDO:0100522, which is why this entry uses the
    approved symbol while the cited snippets say U2HR.

    Reported variant classes are all confined to the 34-codon uORF: loss of the
    initiation codon (c.1A>T, c.2T>C, c.3G>A), delayed/read-through termination
    (c.104A>G, c.105G>T), nonsense (c.67C>T) and missense (c.74C>T, c.74C>G), with
    mutation hot spots at codons 1-7 and 24-28.
  evidence:
  - reference: PMID:19122663
    reference_title: "Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In a large Chinese family carrying MUHH, we identified a pathogenic initiation codon mutation in U2HR, an inhibitory upstream ORF in the 5' UTR of the gene encoding the human hairless homolog (HR)."
    explanation: The founding report identifying U2HR/HRURF as the causal element and locating it in the 5' UTR of HR.
  - reference: PMID:19122663
    reference_title: "Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In 18 more families from different ancestral groups, we identified a range of defects in U2HR, including loss of initiation, delayed termination codon and nonsense and missense mutations."
    explanation: Establishes the allelic spectrum within the uORF across 18 additional unrelated families.
  - reference: PMID:39872230
    reference_title: "Recalcitrant Female Pattern Hair Loss Like Alopecia Unveils Unexpected Rare Entity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Genetic testing confirmed a heterozygous pathogenic variant in the HRURF gene, associated with autosomal dominant Marie Unna Hereditary Hypotrichosis."
    explanation: A recent report using the approved HRURF symbol for the same causal element, confirming heterozygous variants in patients.
- name: HR
  relationship_type: DISPUTED
  variant_origin: GERMLINE
  gene_term:
    preferred_term: HR
    term:
      id: hgnc:5172
      label: HR
  notes: >
    HR (HGNC:5172) is recorded here only to make the relationship explicit, not as a
    second causal gene for HYPT4. HRURF sits inside HR's 5' UTR and the disease acts
    through HR protein output, but the linkage-era studies that mapped MUHH to 8p21
    explicitly excluded the HR coding sequence, and that exclusion is what led to the
    uORF discovery.

    One outlier exists: a single Hungarian patient with alopecia universalis and
    four-limb deformities was reported with a heterozygous HR exon-3 missense variant
    (c.974G>A, p.Gly325Asp) under the label MUHH1 (PMID:22584530). That report is not
    cited as evidence anywhere in this entry. The authors themselves wrote that
    further studies are needed to establish a role for the variant, only one
    unaffected relative was available, the phenotype (alopecia universalis plus limb
    deformity) is not the MUHH1 triphasic course, and no subsequent family has
    replicated a coding-HR cause of MUHH1. Biallelic HR coding loss-of-function
    causes atrichia with papular lesions and alopecia universalis congenita, which
    are recessive and separate entities - see `differential_diagnoses`.
pathophysiology:
- name: HRURF Upstream Open Reading Frame Disruption
  biological_scale: MOLECULAR
  description: >
    A heterozygous germline variant disrupts the 34-codon inhibitory upstream open
    reading frame HRURF (U2HR) in the 5' untranslated region of the HR transcript.
    Loss-of-initiation, delayed-termination, nonsense and missense changes all
    destroy the uORF peptide's normal function. The variant is loss-of-function
    *for the uORF*; its effect on hairless is the opposite (see the next node).
  genetic_context:
    gene:
      preferred_term: HRURF
      term:
        id: hgnc:55085
        label: HRURF
    variant_origin: GERMLINE
    zygosity: HETEROZYGOUS
    functional_impact_category: LOSS_OF_FUNCTION
    description: >
      The category applies to HRURF, whose repressive uORF function is abolished. The
      downstream consequence for HR is increased protein output, which is a different
      claim about a different gene product and is modeled as a separate node.
  biological_processes:
  - preferred_term: uORF-mediated repression of translational initiation at the main HR ORF
    term:
      id: GO:0045947
      label: negative regulation of translational initiation
    modifier: LOSS_OF_FUNCTION
  evidence:
  - reference: PMID:19122663
    reference_title: "Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In 18 more families from different ancestral groups, we identified a range of defects in U2HR, including loss of initiation, delayed termination codon and nonsense and missense mutations."
    explanation: Defines the classes of uORF-disrupting variants that constitute the initiating lesion.
  - reference: PMID:19122663
    reference_title: "Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: "U2HR is predicted to encode a 34-amino acid peptide that is highly conserved among mammals."
    explanation: The uORF peptide length and its mammalian conservation are a sequence prediction, not an experimental measurement, and are graded accordingly.
  - reference: PMID:20163456
    reference_title: "Marie Unna hereditary hypotrichosis caused by a novel mutation in the human hairless transcript."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript were found as the cause for autosomal dominant Marie Unna hereditary hypotrichosis."
    explanation: Independently states that the causal lesion is loss of function of the inhibitory uORF, not of the hairless coding sequence.
  downstream:
  - target: Translational De-repression of the Main HR Open Reading Frame
    causal_link_type: DIRECT
    description: >
      Destroying the uORF removes the translational brake it imposes on the
      downstream main HR ORF.
    evidence:
    - reference: PMID:19122663
      reference_title: "Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Functional analysis showed that these classes of mutations all resulted in increased translation of the main HR physiological ORF."
      explanation: Reporter assays link each class of uORF defect directly to increased translation of the main HR ORF, which is the edge asserted here.
- name: Translational De-repression of the Main HR Open Reading Frame
  biological_scale: MOLECULAR
  description: >
    With the inhibitory uORF disabled, ribosomes translate the downstream main HR
    open reading frame more efficiently. This is the pivotal direction in the entry:
    translation of HR goes *up*, not down.
  biological_processes:
  - preferred_term: translation of the main HR open reading frame
    term:
      id: GO:0006412
      label: translation
    modifier: INCREASED
  evidence:
  - reference: PMID:19122663
    reference_title: "Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Functional analysis showed that these classes of mutations all resulted in increased translation of the main HR physiological ORF."
    explanation: Directly states the increased-translation direction for every reported class of uORF variant.
  - reference: PMID:20163456
    reference_title: "Marie Unna hereditary hypotrichosis caused by a novel mutation in the human hairless transcript."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Functional assays confirmed that this mutation led to increased translation of the main HR ORF."
    explanation: An independent laboratory reproduces the increased-translation result for a further missense uORF variant.
  downstream:
  - target: Hairless Corepressor Protein Overexpression
    causal_link_type: DIRECT
    description: More efficient translation of the main ORF raises HR protein levels.
    evidence:
    - reference: PMID:19897589
      reference_title: "Overexpression of Hr links excessive induction of Wnt signaling to Marie Unna hereditary hypotrichosis."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "This mutation conferred overexpression of HR through translational derepression and, in turn, decreased the expression of Sfrp2, an inhibitor of the Wnt signaling pathway."
      explanation: States the derepression-to-overexpression step explicitly in the mouse carrying the orthologous uORF mutation.
- name: Hairless Corepressor Protein Overexpression
  biological_scale: MOLECULAR
  description: >
    Hairless is a nuclear-receptor transcriptional corepressor expressed mainly in
    skin and brain that governs hair-follicle morphogenesis and cycling. In MUHH1 the
    protein itself is structurally normal; there is simply too much of it. Because HR
    acts by repressing transcription, excess HR means excess corepression at its
    target genes. Hair growth depends on HR being present in the right amount rather
    than merely present, which is why both loss and gain of HR produce alopecia.
  biological_processes:
  - preferred_term: hairless-mediated transcriptional corepression at nuclear-receptor target genes
    term:
      id: GO:0000122
      label: negative regulation of transcription by RNA polymerase II
    modifier: INCREASED
  cell_types:
  - preferred_term: hair follicle keratinocyte
    term:
      id: CL:2000092
      label: hair follicular keratinocyte
  evidence:
  - reference: PMID:24447645
    reference_title: "Increased expression of Dkk1 by HR is associated with alteration of hair cycle in hairpoor mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Hairless (Hr), a transcriptional corepressor expressed mainly in the skin, regulates hair follicle (HF) morphogenesis and hair cycling."
    explanation: Establishes what the overproduced protein does - transcriptional corepression governing follicle morphogenesis and cycling.
  - reference: PMID:19122663
    reference_title: "Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "show that fine-tuning of HR protein levels is important in control of hair growth"
    explanation: States that the quantity of HR protein, not its presence or absence, is the controlled variable in hair growth - the dosage framing of this node.
  - reference: PMID:19897589
    reference_title: "Overexpression of Hr links excessive induction of Wnt signaling to Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "This study indicates that the gain in function of HR also results in alopecia, as seen with the loss of function of HR, via abnormal upregulation of the Wnt signaling pathway."
    explanation: States that gain, not loss, of HR causes the alopecia in this model - the direction this entry curates.
  downstream:
  - target: Dysregulated Wnt Pathway Modulation in the Hair Follicle
    causal_link_type: DIRECT
    description: >
      Excess HR corepressor alters transcription of Wnt-pathway modulator genes in
      follicular skin. Demonstrated in the hairpoor mouse only.
    evidence:
    - reference: PMID:19897589
      reference_title: "Overexpression of Hr links excessive induction of Wnt signaling to Marie Unna hereditary hypotrichosis."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "This mutation conferred overexpression of HR through translational derepression and, in turn, decreased the expression of Sfrp2, an inhibitor of the Wnt signaling pathway."
      explanation: Links HR overexpression to reduced expression of the Wnt inhibitor Sfrp2, the edge asserted here.
    - reference: PMID:24447645
      reference_title: "Increased expression of Dkk1 by HR is associated with alteration of hair cycle in hairpoor mice."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Dkk1 expression was increased in the skin of (+)/Hr(HP) and Hr(Hp)/Hr(Hp) mice, as well as in Hr-overexpressing mouse keratinocytes."
      explanation: An independent Wnt modulator, Dkk1, is also altered by HR overexpression, including in HR-overexpressing keratinocytes.
  - target: Abnormal Hair Shaft Formation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      The coarse, twisted, variable-calibre shafts of MUHH1 arise in follicles
      operating under excess HR corepression. The intervening steps between HR dosage
      and shaft geometry are not established; the link is recorded as indirect and
      the specific cellular step is flagged in `discussions`.
- name: Dysregulated Wnt Pathway Modulation in the Hair Follicle
  biological_scale: CELLULAR
  description: >
    In the hairpoor mouse, HR overexpression changes the expression of secreted Wnt
    inhibitors in follicular skin. The two published results are not concordant in
    sign: Sfrp2 falls (which the authors read as excess Wnt activation), while Dkk1
    rises (a Wnt inhibitor and catagen inducer). The node therefore records the
    pathway as dysregulated rather than asserting a direction, and the discrepancy is
    tracked as an open controversy. Nothing here has been shown in human MUHH1 skin.
  biological_processes:
  - preferred_term: Wnt signaling pathway modulation in follicular skin
    term:
      id: GO:0016055
      label: Wnt signaling pathway
    modifier: DYSREGULATED
  - preferred_term: secreted Wnt-inhibitor (Sfrp2, Dkk1) expression
    term:
      id: GO:0030178
      label: negative regulation of Wnt signaling pathway
    modifier: DYSREGULATED
  evidence:
  - reference: PMID:19897589
    reference_title: "Overexpression of Hr links excessive induction of Wnt signaling to Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "This study indicates that the gain in function of HR also results in alopecia, as seen with the loss of function of HR, via abnormal upregulation of the Wnt signaling pathway."
    explanation: Reports abnormal upregulation of Wnt signaling downstream of HR gain in the hairpoor mouse.
  - reference: PMID:24447645
    reference_title: "Increased expression of Dkk1 by HR is associated with alteration of hair cycle in hairpoor mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "One of the Wnt inhibitors, Dickkopf (Dkk), inhibits hair growth during the hair cycle as a catagen inducer of apoptosis, resulting in HF reductions."
    explanation: Establishes Dkk1's role as a Wnt inhibitor and catagen inducer, the axis the same group found upregulated by HR - the reason this node is labelled dysregulated rather than uniformly activated.
  downstream:
  - target: Premature Catagen Entry and Hair Follicle Shortening
    causal_link_type: DIRECT
    description: >
      Upregulation of the catagen-inducing Wnt inhibitor Dkk1 accompanies early
      catagen entry and shorter follicles in heterozygous hairpoor mice.
    evidence:
    - reference: PMID:24447645
      reference_title: "Increased expression of Dkk1 by HR is associated with alteration of hair cycle in hairpoor mice."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "These findings also indicated that alteration of the hair cycle in (+)/Hr(HP) mice was related to the up-regulation of Dkk1 by HR."
      explanation: The authors attribute the altered hair cycle in the heterozygous model to HR-driven Dkk1 upregulation, which is this edge.
- name: Premature Catagen Entry and Hair Follicle Shortening
  biological_scale: TISSUE
  description: >
    Heterozygous hairpoor mice enter catagen earlier and grow shorter hair follicles
    than wild type. This is the mechanistic proposal for why MUHH1 hair is short and
    why follicles progressively fail; it is a mouse result and has not been shown in
    human MUHH1 scalp.
  biological_processes:
  - preferred_term: hair cycle (anagen-catagen transition)
    term:
      id: GO:0042633
      label: hair cycle
    modifier: ABNORMAL
  evidence:
  - reference: PMID:24447645
    reference_title: "Increased expression of Dkk1 by HR is associated with alteration of hair cycle in hairpoor mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Additionally, an earlier entrance of HFs into catagen and shortened HF length in (+)/Hr(HP) mice compared to wild-type mice was observed."
    explanation: Directly measures earlier catagen entry and shortened follicles in the heterozygous model of MUHH1.
  downstream:
  - target: Progressive Loss of Hair Follicle Density
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Repeated cycles truncated at catagen are the proposed route to permanent
      follicle loss. The step is inferred: no study follows individual human MUHH1
      follicles from shortened cycling to loss.
- name: Progressive Loss of Hair Follicle Density
  biological_scale: TISSUE
  description: >
    Scalp biopsy in MUHH1 shows a markedly reduced number of follicles per unit area
    with only a mild to moderate inflammatory infiltrate, little fibrosis and no
    scarring - a non-scarring alopecia. The mechanism by which follicles are lost was
    explicitly stated as unknown in the largest histopathological pedigree study and
    remains so.
  cell_types:
  - preferred_term: hair follicle keratinocyte
    term:
      id: CL:2000092
      label: hair follicular keratinocyte
  biological_processes:
  - preferred_term: hair follicle development and maintenance
    term:
      id: GO:0001942
      label: hair follicle development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Histologically, there are dramatically reduced numbers of follicles per unit area, averaging nine total hairs per 4 mm cross-section as compared with a normal of 40."
    explanation: Quantifies the loss of follicle density in affected human scalp.
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The mechanism of progressive hair loss is unknown."
    explanation: The authors state directly that the mechanism of follicle loss was not established, which is why this node carries no asserted cellular mechanism.
  - reference: PMID:39872230
    reference_title: "Recalcitrant Female Pattern Hair Loss Like Alopecia Unveils Unexpected Rare Entity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Genetic factors, altered hair shaft morphology, a decreased number of functional follicles, and abnormal follicle cycling have been suggested as contributors to the disease pathogenesis, with mutations in the U2HR gene, located on chromosome 8p21, identified as the underlying cause."
    explanation: A recent molecularly confirmed case series names reduced functional follicle number and abnormal follicle cycling as the proposed contributors, matching this node and the one above it.
  downstream:
  - target: Progressive Scalp Hair Loss After Puberty
    causal_link_type: DIRECT
    description: Loss of follicles is what the patterned post-pubertal alopecia consists of.
- name: Abnormal Hair Shaft Formation
  biological_scale: TISSUE
  description: >
    The hair that does grow is structurally abnormal: shafts of uniformly increased
    and variable diameter (up to 0.12 mm), deeply pigmented, twisted, bent at odd
    angles, longitudinally grooved on scanning electron microscopy, and irregular in
    cross-section. Dermoscopy shows pili torti. This produces the coarse, wiry,
    unruly hair of the childhood phase.
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Individual hair shafts are deeply pigmented, variable in diameter, twisted, and bent at odd angles; some have a longitudinal groove visible on scanning electron microscopy."
    explanation: Structural characterization of the abnormal shaft by light and scanning electron microscopy.
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The hair shafts are uniformly increased in diameter, measuring up to 0.12 mm."
    explanation: Quantifies the increased shaft calibre that gives the hair its coarse quality.
  downstream:
  - target: Coarse Wiry Scalp Hair in Childhood
    causal_link_type: DIRECT
    description: The altered shaft geometry is what makes the hair coarse, wiry and unruly.
  - target: Pili Torti
    causal_link_type: DIRECT
    description: Twisting of the shaft on its own axis is seen dermoscopically as pili torti.
phenotypes:
- category: Cutaneous
  name: Sparse Scalp Hair at Birth
  description: >
    Scalp hair is absent or scanty at birth and through early infancy. Note that this
    is not universal: the six-generation pedigree of Roberts et al. described affected
    individuals as born with adequate, normal to coarse hair, so the congenital phase
    varies between families.
  phenotype_term:
    preferred_term: Sparse scalp hair
    term:
      id: HP:0002209
      label: Sparse scalp hair
  evidence:
  - reference: PMID:20659777
    reference_title: "Marie Unna hereditary hypotrichosis: identification of a U2HR mutation in the family from the original 1925 report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "MUHH is an autosomal dominant disorder that is characterized by the absence or scarcity of scalp hair, eyebrows, and eyelashes at birth; coarse and wiry hair during childhood; and progressive hair loss beginning around puberty."
    explanation: Defines absent or scanty scalp hair at birth as a characteristic feature.
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "Affected individuals are born with adequate, normal to coarse hair."
    explanation: In this large pedigree the neonatal hair was adequate rather than sparse, contradicting the claim that sparse hair at birth is universal.
- category: Cutaneous
  name: Coarse Wiry Scalp Hair in Childhood
  description: >
    During early infancy and childhood the scalp hair becomes coarse, wiry and unruly,
    standing out from the head. This is the most distinctive phase of the disease.
  phenotype_term:
    preferred_term: Coarse hair
    term:
      id: HP:0002208
      label: Coarse hair
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "During early infancy the scalp hair becomes more coarse and wiry and stands out from the head."
    explanation: Direct clinical description of the coarse, wiry childhood hair.
  - reference: PMID:26269244
    reference_title: "Identification of mutations in U2HR in two Chinese families with Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Marie Unna hereditary hypotrichosis (MUHH) is a rare autosomal dominant genodermatosis characterized by coarse, wiry, twisted hair developing during early childhood, with subsequent progressive hair loss."
    explanation: Confirms coarse, wiry, twisted childhood hair as the defining feature in molecularly confirmed families.
  sequelae:
  - target: Progressive Scalp Hair Loss After Puberty
    description: The coarse childhood hair is subsequently lost from around puberty.
- category: Cutaneous
  name: Progressive Scalp Hair Loss After Puberty
  description: >
    From around puberty, scalp hair is progressively lost in a patterned distribution
    that can mimic androgenetic or female-pattern hair loss, in the most advanced
    cases leaving only a sparse fringe in the tonsorial distribution.
  phenotype_term:
    preferred_term: Progressive alopecia
    term:
      id: HP:0002287
      label: Progressive alopecia
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In some individuals, scalp hair is progressively lost beginning at puberty or beyond, until only a sparse fringe in the tonsorial distribution remains."
    explanation: Describes the post-pubertal progressive, patterned scalp hair loss and its endpoint.
  - reference: PMID:39872230
    reference_title: "Recalcitrant Female Pattern Hair Loss Like Alopecia Unveils Unexpected Rare Entity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The study describes two cases from different unrelated families presenting with recalcitrant alopecia resembling female pattern hair loss, with dermoscopic findings consistent with pili torti and yellow dots."
    explanation: Documents that the adult hair loss can present as, and be mistaken for, female pattern hair loss.
- category: Cutaneous
  name: Sparse Eyebrows
  description: >
    Eyebrows are sparse to absent from early life. Eyebrow loss is a useful
    discriminator from androgenetic alopecia in an adult presenting with patterned
    scalp thinning.
  phenotype_term:
    preferred_term: Sparse eyebrow
    term:
      id: HP:0045075
      label: Sparse eyebrow
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected individuals have sparse to absent eyebrows, eyelashes and body hair including secondary sexual hair."
    explanation: Reports sparse to absent eyebrows in all affected members of a 16-affected pedigree.
  - reference: PMID:20814945
    reference_title: "Marie Unna hereditary hypotrichosis: a Turkish family with loss of eyebrows and a U2HR mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We concluded that there may be considerable clinical variations in MUHH, and that eyebrow loss is an important clue for accurate diagnosis."
    explanation: A U2HR-confirmed Turkish family in which eyebrow loss was the diagnostic clue.
- category: Cutaneous
  name: Sparse Eyelashes
  description: Eyelashes are sparse to absent from early life.
  phenotype_term:
    preferred_term: Sparse eyelashes
    term:
      id: HP:0000653
      label: Sparse eyelashes
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected individuals have sparse to absent eyebrows, eyelashes and body hair including secondary sexual hair."
    explanation: Reports sparse to absent eyelashes in all affected individuals of the pedigree.
- category: Cutaneous
  name: Sparse Body Hair
  description: >
    Body hair, including secondary sexual hair, is sparse to absent, so the
    peripubertal development of axillary, pubic and beard hair is deficient.
  phenotype_term:
    preferred_term: Sparse body hair
    term:
      id: HP:0002231
      label: Sparse body hair
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All affected individuals have sparse to absent eyebrows, eyelashes and body hair including secondary sexual hair."
    explanation: Documents sparse to absent body hair including secondary sexual hair.
- category: Cutaneous
  name: Pili Torti
  description: >
    Dermoscopy of the scalp in molecularly confirmed MUHH1 shows pili torti (hairs
    twisted about their long axis) together with yellow dots.
  phenotype_term:
    preferred_term: Pili torti
    term:
      id: HP:0003777
      label: Pili torti
  evidence:
  - reference: PMID:39872230
    reference_title: "Recalcitrant Female Pattern Hair Loss Like Alopecia Unveils Unexpected Rare Entity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The study describes two cases from different unrelated families presenting with recalcitrant alopecia resembling female pattern hair loss, with dermoscopic findings consistent with pili torti and yellow dots."
    explanation: First published dermoscopic description of MUHH, in patients with a confirmed HRURF variant.
- category: Cutaneous
  name: Abnormal Hair Shaft Morphology
  description: >
    Light and scanning electron microscopy show shafts of increased and variable
    diameter, deeply pigmented, twisted, bent at odd angles, longitudinally grooved,
    with variable and irregular oval to reniform cross-sections.
  phenotype_term:
    preferred_term: Abnormal hairshaft morphology
    term:
      id: HP:0003328
      label: Abnormal hairshaft morphology
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cross-sectional shapes are variable and irregular, exhibiting oval, angular to reniform shapes."
    explanation: Documents the irregular hair-shaft cross-sectional morphology.
- category: Dental
  name: Widely Spaced Upper Incisors
  description: >
    Other ectodermal structures are essentially spared, with the reported exception of
    exceptionally widely spaced upper incisor teeth in half the affected individuals
    of one large pedigree. This has not been systematically confirmed in other
    families and should not be treated as an established feature of MUHH1.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Widely-spaced incisors
    term:
      id: HP:0006304
      label: Widely-spaced incisors
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other ectodermal structures are unaffected except for exceptionally widely spaced upper incisor teeth seen in 50% of affected individuals."
    explanation: Reports widely spaced upper incisors in 50% of affected individuals, supporting both the finding and its FREQUENT band, while confirming that other ectodermal structures are spared.
histopathology:
- name: Reduced Follicular Density on Scalp Biopsy
  description: >
    Horizontal sections show a dramatic reduction in the number of follicles per unit
    area - about nine total hairs per 4 mm cross-section against a normal of 40.
  diagnostic: true
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Histologically, there are dramatically reduced numbers of follicles per unit area, averaging nine total hairs per 4 mm cross-section as compared with a normal of 40."
    explanation: The quantitative histopathological finding on scalp biopsy.
- name: Mild Inflammatory Infiltrate Without Scarring
  description: >
    A mild to moderate inflammatory infiltrate is present, but there is little
    fibrosis and no scarring - MUHH1 is a non-scarring alopecia, which separates it
    from the cicatricial alopecias.
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A mild to moderate inflammatory infiltrate is present, but little fibrosis and no scarring."
    explanation: Establishes the non-scarring character of the alopecia and the presence of only a modest infiltrate.
diagnosis:
- name: HRURF (U2HR) Sequencing
  description: >
    Diagnosis is confirmed by sequencing the small HRURF/U2HR upstream open reading
    frame in the 5' UTR of HR. This is a clinically important pitfall: the element is
    non-coding with respect to HR, so an HR coding-exon panel, or an exome pipeline
    that does not annotate this UTR-embedded ORF, will miss the causal variant. That
    is exactly why linkage mapped MUHH to 8p21 in 2000 but the causal element was not
    found until 2009.
  markers: Heterozygous pathogenic variant within the 34-codon HRURF (U2HR) upstream open reading frame in the 5' UTR of HR at 8p21.3.
  results: >
    A heterozygous loss-of-initiation, delayed-termination, nonsense or missense HRURF
    variant in a patient with the characteristic hair phenotype confirms MUHH1.
  evidence:
  - reference: PMID:19122663
    reference_title: "Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In a large Chinese family carrying MUHH, we identified a pathogenic initiation codon mutation in U2HR, an inhibitory upstream ORF in the 5' UTR of the gene encoding the human hairless homolog (HR)."
    explanation: Identifies the region that must be sequenced to make the molecular diagnosis.
  - reference: PMID:20659777
    reference_title: "Marie Unna hereditary hypotrichosis: identification of a U2HR mutation in the family from the original 1925 report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Direct sequencing of U2HR was performed."
    explanation: Direct sequencing of the U2HR element is the method used to make the molecular diagnosis in practice.
  - reference: PMID:30809827
    reference_title: "Marie Unna hereditary hypotrichosis accompanied by multiple familial trichoepithelioma in a Chinese family."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found that the c.1A>G mutation in an inhibitory upstream open-reading frame of HR (U2HR) was present in all MUHH patients"
    explanation: Sanger sequencing of the U2HR element identified the causal variant in every affected family member.
  diagnosis_term:
    preferred_term: HRURF (U2HR) sequencing
    term:
      id: NCIT:C19770
      label: Molecular Analysis
- name: Trichoscopy and Hair Shaft Microscopy
  description: >
    Clinical diagnosis rests on the triphasic history plus examination of the hair
    itself. Trichoscopy shows pili torti and yellow dots; light microscopy and
    scanning electron microscopy of plucked shafts show increased and variable
    diameter, twisting, angular bending, longitudinal grooving and irregular
    cross-sections. These findings support the diagnosis but are not specific enough
    to replace HRURF sequencing.
  markers: Pili torti and yellow dots on trichoscopy; twisted, longitudinally grooved hair shafts of increased and variable diameter on microscopy.
  evidence:
  - reference: PMID:39872230
    reference_title: "Recalcitrant Female Pattern Hair Loss Like Alopecia Unveils Unexpected Rare Entity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The study describes two cases from different unrelated families presenting with recalcitrant alopecia resembling female pattern hair loss, with dermoscopic findings consistent with pili torti and yellow dots."
    explanation: Provides the dermoscopic (trichoscopic) findings used to support the diagnosis.
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Individual hair shafts are deeply pigmented, variable in diameter, twisted, and bent at odd angles; some have a longitudinal groove visible on scanning electron microscopy."
    explanation: Describes what hair-shaft light and scanning electron microscopy show in this disease.
  diagnosis_term:
    preferred_term: trichoscopy and hair shaft microscopy
    term:
      id: NCIT:C124351
      label: Clinical Evaluation
differential_diagnoses:
- name: Atrichia with papular lesions / alopecia universalis congenita
  description: >
    Caused by biallelic loss-of-function variants in the HR *coding* sequence -
    the opposite direction of HR dysfunction from MUHH1, and recessive rather than
    dominant. Presents as complete, permanent alopecia from infancy with papular
    lesions, without the coarse-wiry childhood phase. Conflating these entities with
    MUHH1 because both involve HR is the main naming hazard around this locus.
  distinguishing_features:
  - Autosomal recessive rather than dominant
  - Biallelic loss-of-function variants in the HR coding sequence, not in the HRURF uORF
  - Total irreversible alopecia from infancy with papular lesions
  - No coarse, wiry childhood hair phase
  evidence:
  - reference: PMID:24898506
    reference_title: "[Alopecia and hypotrichosis in childhood: clinical features and diagnosis]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna"
    explanation: A clinical review separating the causal genes of the isolated alopecias, listing the HR gene for atrichia congenita and U2HR for Marie Unna type hypotrichosis as distinct entries.
- name: Hypotrichosis 5 (MUHH2)
  description: >
    The sibling MONDO concept under the same parent grouping. Exome sequencing in a
    single four-generation Chinese family mapped to 1p21.1-1q21.3 identified a
    heterozygous EPS8L3 missense variant. It is phenotypically overlapping but
    genetically distinct, and is a separate disease entry, not a subtype of HYPT4.
    Support rests on one family; subsequent MUHH cohorts have not replicated it.
  disease_term:
    preferred_term: hypotrichosis 5
    term:
      id: MONDO:0013017
      label: hypotrichosis 5
  distinguishing_features:
  - Maps to 1p21.1-1q21.3 rather than to 8p21.3
  - Attributed to EPS8L3 rather than to HRURF
  - No HRURF/U2HR variant identified in the reported family
  evidence:
  - reference: PMID:23099647
    reference_title: "Exome sequencing identified a missense mutation of EPS8L3 in Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We identified a missense mutation in EPS8L3 (NM_024526.3: exon2: c.22G->A:p.Ala8Thr) within 1p21.1-1q21.3."
    explanation: Identifies a different gene at a different locus in a family with a MUHH phenotype, establishing the entity as genetically distinct from HYPT4.
- name: Autosomal recessive woolly hair / hypotrichosis
  description: >
    Biallelic LIPH or LPAR6 variants disrupt the LIPH-LPA-LPAR6 axis, giving tightly
    curled woolly hair with hypotrichosis from birth. Recessive, and the hair is
    kinky/woolly rather than the coarse wiry hair of MUHH1.
  distinguishing_features:
  - Autosomal recessive, frequently in consanguineous families
  - Tightly curled woolly hair from birth
  - No triphasic sparse-then-coarse-then-lost natural history
  evidence:
  - reference: PMID:24898506
    reference_title: "[Alopecia and hypotrichosis in childhood: clinical features and diagnosis]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna"
    explanation: Places LIPH and LPAR6 in the recessive hypotrichosis group, distinct from the U2HR-related Marie Unna type.
- name: Androgenetic / female pattern hair loss
  description: >
    The adult MUHH1 phenotype can closely mimic patterned hair loss and has been
    misdiagnosed as recalcitrant female pattern hair loss. The congenital and
    childhood phases, sparse eyebrows and eyelashes, and abnormal hair shafts
    distinguish it.
  distinguishing_features:
  - No congenital sparse-hair phase and no coarse, wiry childhood hair
  - Eyebrows, eyelashes and body hair are normal
  - Hair shafts are structurally normal on microscopy
  evidence:
  - reference: PMID:39872230
    reference_title: "Recalcitrant Female Pattern Hair Loss Like Alopecia Unveils Unexpected Rare Entity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The study describes two cases from different unrelated families presenting with recalcitrant alopecia resembling female pattern hair loss, with dermoscopic findings consistent with pili torti and yellow dots."
    explanation: Documents MUHH1 presenting as, and being mistaken for, recalcitrant female pattern hair loss.
prevalence:
- population: Worldwide
  measure_type: UNKNOWN
  prevalence_class: RARE
  notes: >-
    No numeric prevalence or incidence estimate for HYPT4/MUHH1 was found. Sources
    describe the disease only qualitatively as rare; the measure they intend is not
    stated, so `measure_type` is UNKNOWN and no rate is recorded. Orphanet does index
    the parent concept Marie Unna hereditary hypotrichosis as ORPHA:444, but that code
    is not present in the Orphadata leaf-disorder bulk file this repository caches, so
    no ORPHA-quoted epidemiology row could be curated.
  evidence:
  - reference: PMID:26269244
    reference_title: "Identification of mutations in U2HR in two Chinese families with Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Marie Unna hereditary hypotrichosis (MUHH) is a rare autosomal dominant genodermatosis characterized by coarse, wiry, twisted hair developing during early childhood, with subsequent progressive hair loss."
    explanation: Characterizes the disease as rare, which is the only occurrence claim the literature supports.
progression:
- phase: Congenital and infantile
  notes: >
    Scalp hair, eyebrows and eyelashes are absent or scanty at birth in most reported
    families, although one large pedigree described normal to coarse neonatal hair.
  evidence:
  - reference: PMID:40433810
    reference_title: "Clinical Presentation of a Family Diagnosed With Marie Unna Hereditary Hypotrichosis 1 Caused by a Novel Variant in HRURF."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Marie Unna hereditary hypotrichosis 1 (MUHH1) is a rare autosomal dominant condition characterized by the absence or scarcity of hair at birth with the growth of coarse, wiry, and unruly hair during childhood and progressive hair loss after puberty."
    explanation: States the congenital phase of the natural history in a recent HRURF-confirmed family.
- phase: Childhood
  notes: >
    Coarse, wiry, unruly hair grows in and stands out from the head. Hair shafts are
    thick, twisted, grooved and irregular in cross-section.
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "During early infancy the scalp hair becomes more coarse and wiry and stands out from the head."
    explanation: Describes the childhood phase of the natural history.
- phase: Post-pubertal
  notes: >
    Progressive patterned scalp hair loss begins around puberty and continues into
    adulthood, in some individuals leaving only a tonsorial fringe. At least one
    family member has been reported with the opposite course - progressive scalp hair
    growth during adulthood - so the post-pubertal trajectory is not uniform.
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In some individuals, scalp hair is progressively lost beginning at puberty or beyond, until only a sparse fringe in the tonsorial distribution remains."
    explanation: Describes the post-pubertal progressive loss and its most advanced endpoint.
  - reference: PMID:40433810
    reference_title: "Clinical Presentation of a Family Diagnosed With Marie Unna Hereditary Hypotrichosis 1 Caused by a Novel Variant in HRURF."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This case report describes the clinical presentation of three Danish family members with congenital hypotrichosis with a new phenotypic variation marked by progressive scalp hair growth during adulthood in one of the members."
    explanation: Documents a family member whose adult course was hair growth rather than loss, supporting the statement that the post-pubertal trajectory is not uniform.
treatments:
- name: Genetic Counseling and Supportive Hair Care
  description: >
    There is no disease-modifying therapy. Management is genetic counseling for the
    50% transmission risk of a dominant trait, molecular confirmation of the family
    variant, and cosmetic/supportive measures (gentle hair care, camouflage, wigs).
    This entry states that plainly rather than listing aspirational options.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  therapeutic_modality: BEHAVIORAL
  evidence:
  - reference: PMID:24898506
    reference_title: "[Alopecia and hypotrichosis in childhood: clinical features and diagnosis]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Therapy does not exist for these rare forms of alopecia. However, molecular genetic diagnosis is possible for the identification of the genetic causes and for the specification of the recurrence risk."
    explanation: States both halves of current management - no therapy exists, and molecular diagnosis serves recurrence-risk counseling.
- name: Topical Minoxidil
  description: >
    A single 2025 case report describes significant hair regrowth on once-daily 5%
    topical minoxidil in a child with a recurrent HRURF variant. This is one patient
    and is not established therapy for MUHH1; it is recorded so the lead is
    discoverable, not as a recommendation.
  treatment_term:
    preferred_term: topical pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: minoxidil
      term:
        id: CHEBI:6942
        label: minoxidil
  therapeutic_modality: SMALL_MOLECULE
  notes: >
    Deliberately carries no evidence item. The source is Cui et al., J Cosmet Dermatol
    2025, DOI:10.1111/jocd.70382 (PMC12340736), listed in the top-level `references:`
    block. The local DOI_10.1111_jocd.70382.md cache contains bibliographic metadata
    without an abstract or full text. Europe PMC indexes the letter as PMC12340736
    without a PMID and provides open full text; the missing local body does not mean
    that the source has no quotable text. The claim remains unevidenced here pending
    retrieval and verification of a substantive passage from that full text.
animal_models:
- name: Hairpoor mouse (Hr^Hp)
  species: Mouse
  genotype: Hr^Hp/+ heterozygous and Hr^Hp/Hr^Hp homozygous; T-to-A transversion at nucleotide 403 abolishing the uATG of the second uORF in the Hr 5' UTR
  category: Genetic
  publication: PMID:19513791
  description: >
    An ENU-derived mouse carrying the mutation orthologous to human MUHH1 variants -
    in the start codon of the second uORF in the Hr 5' UTR. It is the only in vivo
    model of the uORF-dosage mechanism, and every downstream mechanistic claim in this
    entry beyond "translation of HR increases" comes from it.
  genes:
  - preferred_term: Hr
    term:
      id: hgnc:5172
      label: HR
  evidence:
  - reference: PMID:19513791
    reference_title: "A novel mutation in Hr causes abnormal hair follicle morphogenesis in hairpoor mouse, an animal model for Marie Unna Hereditary Hypotrichosis."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Both mutations were in the uATG codon of the second uORF in the 5' UTR and corresponded to the mutations identified in Marie Unna Hereditary Hypotrichosis (MUHH) patients."
    explanation: Establishes that the mouse lesion is at the same uORF start codon as the human MUHH variants, which is what makes the model mechanism-matched.
  modeled_mechanisms:
  - target: Translational De-repression of the Main HR Open Reading Frame
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: MOLECULAR
    description: >
      The mouse uATG mutation abolishes the same uORF and produces HR overexpression
      by translational derepression, the same molecular event as in human MUHH1.
    limitations: >
      The allele behaves as semidominant in the mouse - homozygotes are completely
      bald with cyst-like follicles, a state with no human counterpart, since human
      MUHH1 is described only in heterozygotes. Several mechanistic results in this
      model were obtained from homozygotes or from HR-overexpressing keratinocytes
      rather than from the heterozygote that corresponds to the human genotype.
    evidence:
    - reference: PMID:19897589
      reference_title: "Overexpression of Hr links excessive induction of Wnt signaling to Marie Unna hereditary hypotrichosis."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "This mutation conferred overexpression of HR through translational derepression and, in turn, decreased the expression of Sfrp2, an inhibitor of the Wnt signaling pathway."
      explanation: Shows the model reproduces translational derepression and HR overexpression, the node it is linked to.
  - target: Dysregulated Wnt Pathway Modulation in the Hair Follicle
    relationship: MEASURES
    fidelity: LOW
    model_scale: MOLECULAR
    description: >
      This model is the sole source of the Wnt-modulation claim; it measures Sfrp2 and
      Dkk1 transcript and protein levels in mutant skin.
    limitations: >
      The link extrapolates upward: the measurements are transcript and protein levels
      in mouse skin, while the node asserts a cell-level change in Wnt pathway
      activity in the hair follicle. No Wnt pathway readout has been reported in human
      MUHH1 scalp at all, and the two reported modulator changes point in opposite
      directions on net Wnt activity.
    readouts:
    - name: Sfrp2 expression in mutant skin
      target: Dysregulated Wnt Pathway Modulation in the Hair Follicle
      direction: DECREASED
      interpretation: Reduced secreted Wnt inhibitor, read by the authors as excess Wnt activation.
      evidence:
      - reference: PMID:19897589
        reference_title: "Overexpression of Hr links excessive induction of Wnt signaling to Marie Unna hereditary hypotrichosis."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "This mutation conferred overexpression of HR through translational derepression and, in turn, decreased the expression of Sfrp2, an inhibitor of the Wnt signaling pathway."
        explanation: Reports the direction of the Sfrp2 measurement in this model.
    - name: Dkk1 expression in mutant skin and HR-overexpressing keratinocytes
      target: Dysregulated Wnt Pathway Modulation in the Hair Follicle
      direction: INCREASED
      interpretation: >
        Increased secreted Wnt inhibitor and catagen inducer - the opposite sign from
        the Sfrp2 result.
      evidence:
      - reference: PMID:24447645
        reference_title: "Increased expression of Dkk1 by HR is associated with alteration of hair cycle in hairpoor mice."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Dkk1 expression was increased in the skin of (+)/Hr(HP) and Hr(Hp)/Hr(Hp) mice, as well as in Hr-overexpressing mouse keratinocytes."
        explanation: Reports the direction of the Dkk1 measurement in this model.
  - target: Premature Catagen Entry and Hair Follicle Shortening
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: TISSUE
    description: >
      Heterozygous hairpoor mice enter catagen earlier and have shorter follicles than
      wild type, measured directly by hair-cycle staging and follicle length.
    limitations: >
      Premature catagen entry has never been demonstrated in human MUHH1 scalp; the
      only human histopathology available is a cross-sectional follicle count. The
      mouse hair cycle is synchronized and wave-like whereas the human scalp cycles
      asynchronously, so timing results do not transfer directly.
    readouts:
    - name: Hair follicle length and hair-cycle stage
      target: Premature Catagen Entry and Hair Follicle Shortening
      direction: DECREASED
      interpretation: Shorter follicles and earlier catagen entry in heterozygous mutants.
      evidence:
      - reference: PMID:24447645
        reference_title: "Increased expression of Dkk1 by HR is associated with alteration of hair cycle in hairpoor mice."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Additionally, an earlier entrance of HFs into catagen and shortened HF length in (+)/Hr(HP) mice compared to wild-type mice was observed."
        explanation: The direct measurement of follicle length and catagen timing in this model.
    evidence:
    - reference: PMID:19513791
      reference_title: "A novel mutation in Hr causes abnormal hair follicle morphogenesis in hairpoor mouse, an animal model for Marie Unna Hereditary Hypotrichosis."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Hair follicles (HFs) of Hr(Hp)/+ mice underwent normal cycling and appeared normal, although smaller than those of the wild-type mice."
      explanation: Independently reports smaller follicles in the heterozygote, the genotype that corresponds to human MUHH1.
  - target: Progressive Loss of Hair Follicle Density
    relationship: PARTIALLY_RECAPITULATES
    fidelity: LOW
    model_scale: TISSUE
    description: >
      Heterozygous mutants have sparse, short hair progressing towards near alopecia,
      broadly paralleling the human progressive loss.
    limitations: >
      The mouse phenotype is not the human natural history. Human MUHH1 is triphasic -
      sparse at birth, coarse and wiry in childhood, then patterned loss from puberty -
      and the model has no counterpart to the childhood coarse-wiry phase or to the
      pubertal inflection point. No follicle-density quantification in the mutant was
      reported for comparison with the human count of nine hairs per 4 mm section.
    evidence:
    - reference: PMID:19513791
      reference_title: "A novel mutation in Hr causes abnormal hair follicle morphogenesis in hairpoor mouse, an animal model for Marie Unna Hereditary Hypotrichosis."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "These mice display sparse and short hair in the Hr(Hp)/+ heterozygous state and complete baldness in the Hr(Hp)/Hr(Hp) homozygous state."
      explanation: Describes both the partial resemblance in the heterozygote and the homozygous phenotype that has no human counterpart.
    - reference: PMID:19897589
      reference_title: "Overexpression of Hr links excessive induction of Wnt signaling to Marie Unna hereditary hypotrichosis."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Hairpoor mouse mutants display partial hair loss at an early age and progress to near alopecia, which resembles the MUHH phenotype."
      explanation: The authors' own assessment of how far the model resembles the human phenotype.
discussions:
- discussion_id: muhh1_wnt_direction
  kind: CONTROVERSY
  status: OPEN
  prompt: >
    Does hairless overexpression in MUHH1 raise or lower net Wnt/beta-catenin activity
    in the hair follicle?
  attaches_to:
  - pathophysiology#Dysregulated Wnt Pathway Modulation in the Hair Follicle
  rationale: >
    Both published answers come from the same group working in the same hairpoor
    mouse, and they point in opposite directions. In 2010 they reported that HR
    overexpression decreases Sfrp2, a secreted Wnt inhibitor, and concluded that
    alopecia follows from abnormal upregulation of Wnt signaling. In 2014 they
    reported that HR overexpression increases Dkk1, also a secreted Wnt inhibitor and
    a catagen inducer, and concluded that Dkk1 upregulation drives the follicular
    abnormality. Increasing one Wnt inhibitor while decreasing another does not yield
    a single net direction, and no study measures a direct Wnt/beta-catenin pathway
    output such as nuclear beta-catenin or Axin2/Lef1 transcription in the mutant
    follicle. Until such a readout exists the pathway node is curated as DYSREGULATED
    rather than INCREASED, and any downstream reasoning that assumes "excess Wnt" in
    MUHH1 is running ahead of the data.
  evidence:
  - reference: PMID:19897589
    reference_title: "Overexpression of Hr links excessive induction of Wnt signaling to Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "This mutation conferred overexpression of HR through translational derepression and, in turn, decreased the expression of Sfrp2, an inhibitor of the Wnt signaling pathway."
    explanation: The result read as increased Wnt activity - one side of the discrepancy.
  - reference: PMID:24447645
    reference_title: "Increased expression of Dkk1 by HR is associated with alteration of hair cycle in hairpoor mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Dkk1 expression was increased in the skin of (+)/Hr(HP) and Hr(Hp)/Hr(Hp) mice, as well as in Hr-overexpressing mouse keratinocytes."
    explanation: The result pointing the other way - a second Wnt inhibitor going up rather than down.
- discussion_id: muhh1_human_mechanism_gap
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >
    Does anything downstream of increased HR translation - Wnt modulator change,
    premature catagen, follicle shortening - actually occur in human MUHH1 scalp?
  attaches_to:
  - pathophysiology#Dysregulated Wnt Pathway Modulation in the Hair Follicle
  - pathophysiology#Premature Catagen Entry and Hair Follicle Shortening
  rationale: >
    The human evidence stops early. Increased translation of the main HR ORF is shown
    in human reporter assays, and reduced follicle density is shown in human scalp
    biopsy. Everything in between - the Wnt modulator changes, earlier catagen entry,
    and follicle shortening - comes from the hairpoor mouse alone, and that model is
    semidominant with a homozygous phenotype (complete baldness, cystic follicles)
    that has no human counterpart. The largest human histopathological study states
    outright that the mechanism of progressive hair loss is unknown, and no
    transcriptomic, proteomic or single-cell dataset from MUHH1 follicles was found.
    So the entry's middle nodes are model-derived and should be read that way. The
    resolving experiments would be a scalp-biopsy hair-cycle and Wnt-target readout in
    genotyped MUHH1 patients, and a heterozygous knock-in of a human HRURF variant.
  evidence:
  - reference: PMID:10674378
    reference_title: "Marie Unna congenital hypotrichosis: clinical description, histopathology, scanning electron microscopy of a previously unreported large pedigree."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The mechanism of progressive hair loss is unknown."
    explanation: The human histopathological study explicitly leaves the follicle-loss mechanism open, which is the gap this discussion records.
  - reference: PMID:19513791
    reference_title: "A novel mutation in Hr causes abnormal hair follicle morphogenesis in hairpoor mouse, an animal model for Marie Unna Hereditary Hypotrichosis."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "These mice display sparse and short hair in the Hr(Hp)/+ heterozygous state and complete baldness in the Hr(Hp)/Hr(Hp) homozygous state."
    explanation: Shows the model's semidominant behaviour, the specific respect in which it diverges from the human heterozygous-only disease.
- discussion_id: muhh1_gene_symbol_attribution
  kind: OPEN_QUESTION
  status: OPEN
  prompt: >
    Should MUHH1 variants be attributed to HRURF as a gene, or to a regulatory element
    of HR?
  attaches_to:
  - genetic#HRURF
  - genetic#HR
  rationale: >
    Every primary report from 2009 to 2023 describes the lesion as being in "U2HR, an
    inhibitory upstream open reading frame in the 5' UTR of the human hairless gene" -
    that is, as a regulatory element of HR, not as a separate gene. HGNC approved
    HRURF as its own protein-coding gene record only in 2020, and reports from 2025
    onward use that symbol while glossing it as "formerly U2HR". MONDO records
    HGNC:55085 as the causal gene for MONDO:0100522, and this entry follows that. The
    open question is practical rather than nomenclatural: variant-calling pipelines and
    gene panels built around HR coding exons do not report this element, which is why
    the causal variant escaped detection for nine years after the locus was mapped, and
    a panel that lists "HR" is not necessarily testing HRURF.
  evidence:
  - reference: PMID:19122663
    reference_title: "Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In a large Chinese family carrying MUHH, we identified a pathogenic initiation codon mutation in U2HR, an inhibitory upstream ORF in the 5' UTR of the gene encoding the human hairless homolog (HR)."
    explanation: The founding paper describes the element as a uORF within HR's 5' UTR, using the U2HR name.
  - reference: PMID:40433810
    reference_title: "Clinical Presentation of a Family Diagnosed With Marie Unna Hereditary Hypotrichosis 1 Caused by a Novel Variant in HRURF."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A novel likely pathogenic variant c.105G>T (p.(*35Tyrext*?)) in HRURF, formerly known as U2HR, causing MUHH1 was identified."
    explanation: A recent report using the approved HRURF symbol and stating explicitly that it is the former U2HR, confirming the two names denote one element.
notes: >
  Lump/split. MONDO:0100522 is curated here as a disease, not as a subtype or a
  grouping. Its MONDO parent, MONDO:0018631 "Marie Unna hereditary hypotrichosis",
  has exactly two children - this concept (MUHH1, causal gene HGNC:55085 HRURF at
  8p21.3) and MONDO:0013017 hypotrichosis 5 (MUHH2, attributed to EPS8L3 at
  1p21.1-1q21.3). Two different loci with different causal genes make those siblings,
  not subtypes of one another, and make the parent a union of two diseases rather than
  a disease itself. MUHH2 is therefore recorded under `differential_diagnoses`, not
  under `has_subtypes`, and the parent is recorded as a `skos:broadMatch`
  cross-reference. If MONDO:0018631 is ever curated it belongs in `kb/groupings/`.

  No `conforms_to` module target was found. There is no hair-follicle-cycle or
  hair-follicle-morphogenesis module in `kb/modules/`. The nearest candidates were
  checked and rejected: `eda_edar_nfkb_ectodermal_appendage` scopes itself to the
  EDA-EDAR-EDARADD-NF-kappaB pathway ectodermal dysplasias, and MUHH1 involves no part
  of that pathway; `keratin_intermediate_filament_fragility` requires a keratin variant
  and there is none here.

  Claims found in sources but not curated. A single Hungarian patient with alopecia
  universalis and four-limb deformities was reported with a heterozygous HR exon-3
  missense variant under the MUHH1 label (PMID:22584530); the authors called for
  further study, the phenotype is not the MUHH1 course, and no family has replicated
  it, so it is described in `genetic` notes rather than curated as a mechanism. A
  five-generation Chinese family had MUHH co-occurring with multiple familial
  trichoepithelioma, but the authors concluded the accompanying FABP12 variant was
  probably coincidental (PMID:30809827), so no comorbidity is asserted. Follicular
  hyperkeratosis with milia-like facial papules is mentioned in secondary sources as a
  variable accessory feature; no cached source stated it in quotable form, so it is
  not curated.

  Deep research. The committed report is a `claude_code` report
  (`research/Hypotrichosis_4-deep-research-claude_code.md`). Falcon returns HTTP 402
  and openscientist was timing out server-side at the time of curation, so neither was
  used. `just preflight-dr` returned WARN because HR is mentioned more often than
  HRURF; that is intrinsic to a disease whose causal element sits inside another
  gene's 5' UTR, and disease identity was confirmed independently - MONDO:0100522
  carries OMIM:146550 and RO:0004003 HGNC:55085, both matching the report.
📚

References & Deep Research

References

2
Significant Hair Regrowth With 5% Topical Minoxidil in a Child With Marie Unna Hereditary Hypotrichosis Caused by a Recurrent <scp><i>HRURF</i></scp> Variant
No top-level findings curated for this source.
A newly identified missense mutation of the HR gene is associated with a novel, unusual phenotype of Marie Unna Hereditary Hypotrichosis 1 including limb deformities.
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (2)

Record notes

Lump/split. MONDO:0100522 is curated here as a disease, not as a subtype or a grouping. Its MONDO parent, MONDO:0018631 "Marie Unna hereditary hypotrichosis", has exactly two children - this concept (MUHH1, causal gene HGNC:55085 HRURF at 8p21.3) and MONDO:0013017 hypotrichosis 5 (MUHH2, attributed to EPS8L3 at 1p21.1-1q21.3). Two different loci with different causal genes make those siblings, not subtypes of one another, and make the parent a union of two diseases rather than a disease itself. MUHH2 is therefore recorded under `differential_diagnoses`, not under `has_subtypes`, and the parent is recorded as a `skos:broadMatch` cross-reference. If MONDO:0018631 is ever curated it belongs in `kb/groupings/`. No `conforms_to` module target was found. There is no hair-follicle-cycle or hair-follicle-morphogenesis module in `kb/modules/`. The nearest candidates were checked and rejected: `eda_edar_nfkb_ectodermal_appendage` scopes itself to the EDA-EDAR-EDARADD-NF-kappaB pathway ectodermal dysplasias, and MUHH1 involves no part of that pathway; `keratin_intermediate_filament_fragility` requires a keratin variant and there is none here. Claims found in sources but not curated. A single Hungarian patient with alopecia universalis and four-limb deformities was reported with a heterozygous HR exon-3 missense variant under the MUHH1 label (PMID:22584530); the authors called for further study, the phenotype is not the MUHH1 course, and no family has replicated it, so it is described in `genetic` notes rather than curated as a mechanism. A five-generation Chinese family had MUHH co-occurring with multiple familial trichoepithelioma, but the authors concluded the accompanying FABP12 variant was probably coincidental (PMID:30809827), so no comorbidity is asserted. Follicular hyperkeratosis with milia-like facial papules is mentioned in secondary sources as a variable accessory feature; no cached source stated it in quotable form, so it is not curated. Deep research. The committed report is a `claude_code` report (`research/Hypotrichosis_4-deep-research-claude_code.md`). Falcon returns HTTP 402 and openscientist was timing out server-side at the time of curation, so neither was used. `just preflight-dr` returned WARN because HR is mentioned more often than HRURF; that is intrinsic to a disease whose causal element sits inside another gene's 5' UTR, and disease identity was confirmed independently - MONDO:0100522 carries OMIM:146550 and RO:0004003 HGNC:55085, both matching the report.

Create: Hypotrichosis_4 · 2026-09-07T22:31:45Z · View source

New entry for hypotrichosis 4 (HYPT4 / Marie Unna hereditary hypotrichosis 1, MONDO:0100522). Lump/split. Curated as a DISEASE, not a subtype or grouping. MONDO:0018631 'Marie Unna hereditary hypotrichosis' has exactly two children in MONDO: MONDO:0100522 (MUHH1, causal gene HGNC:55085 HRURF at 8p21.3, confirmed as the RO:0004003 edge in the local MONDO build) and MONDO:0013017 (hypotrichosis 5 / MUHH2, attributed to EPS8L3 at 1p21.1-1q21.3). Two distinct causal loci make those siblings, so MUHH2 is recorded under differential_diagnoses rather than has_subtypes, and the parent is a skos:broadMatch cross-reference only. If MONDO:0018631 is ever curated it belongs in kb/groupings/. Mechanism direction. The lesion is translational DE-REPRESSION, not loss of hairless function, and the entry is written to keep that straight. Node 1 (HRURF uORF disruption) carries genetic_context functional_impact_category LOSS_OF_FUNCTION against HRURF, whose repressive uORF function is destroyed, with an explicit description saying the category applies to the uORF and not to HR. Node 2 (translational de-repression) carries GO:0006412 translation with modifier INCREASED, cited to two independent functional-assay results (PMID:19122663 'increased translation of the main HR physiological ORF'; PMID:20163456 'increased translation of the main HR ORF'). Node 3 is HR corepressor overexpression with GO:0000122 modifier INCREASED. No node anywhere asserts reduced HR function. Gene attribution, checked against the primary literature rather than assumed. Every primary report from 2009 (PMID:19122663) through 2023 (PMID:37012647) attributes the variants to U2HR, described as an inhibitory uORF inside the 5' UTR of HR. HGNC approved HRURF (HGNC:55085, alias U2HR) as a separate gene record only in 2020-12-16; reports from 2025 on (PMID:40433810, PMID:39872230) use HRURF and gloss it as formerly U2HR. Both hgnc:55085 and hgnc:5172 were confirmed present in the HGNC build. The entry binds hgnc:55085 as CAUSATIVE, matching MONDO, and records a discussion (muhh1_gene_symbol_attribution) on the practical consequence: an HR coding-exon panel does not test this element. HR is recorded as a second genetic entry with relationship_type DISPUTED and no evidence, purely to make the relationship explicit. The one report of a coding HR missense variant under a MUHH1 label (PMID:22584530, alopecia universalis plus four-limb deformities) is described in notes, not curated as a mechanism: the authors themselves called for further study, the phenotype is not the MUHH1 triphasic course, and no family has replicated it. Downstream mechanism honesty. Everything between increased HR translation and reduced human follicle density comes from the hairpoor mouse alone. Two discussions record this: muhh1_wnt_direction (CONTROVERSY) because the same group reported Sfrp2 DOWN in 2010, read as excess Wnt, and Dkk1 UP in 2014, a Wnt inhibitor and catagen inducer, so the Wnt node is curated DYSREGULATED rather than INCREASED; and muhh1_human_mechanism_gap (HUMAN_MODEL_MISMATCH) because no Wnt or hair-cycle readout exists in human MUHH1 scalp and PMID:10674378 states outright that the mechanism of hair loss is unknown. The hairpoor mouse is curated in animal_models with four modeled_mechanisms links carrying model_scale, fidelity, limitations and readouts; the Wnt link is MEASURES/LOW with an explicit upward-extrapolation caveat. A REFUTE evidence item is curated on the 'Sparse Scalp Hair at Birth' phenotype: PMID:10674378 describes affected individuals as 'born with adequate, normal to coarse hair', contradicting the usual statement that congenital sparse hair is universal. Deep research. The committed report is a claude_code report (research/Hypotrichosis_4-deep-research-claude_code.md; 5m14s, 16 web searches, 26 citations). falcon was not attempted because it returns HTTP 402 (out of credits) and openscientist because it was timing out server-side; no fallback substitution was made. just validate-research-reference and validate-research-terms were run and their sections committed with the report: 14/14 references resolved, 0 unresolved, 0 off topic; term validation flagged MONDO:0007806 as obsolete (replaced by MONDO:0100522, which this entry binds), GO:0070577 as obsolete (not used), and HP:0002293 as mislabelled by the report ('Hypotrichosis'; HPO calls it 'Alopecia of scalp') - that term was NOT bound. just preflight-dr returned WARN because HR is mentioned 71 times against HRURF 22; that is intrinsic to a disease whose causal element sits inside another gene's 5' UTR, and identity was confirmed independently against MONDO (OMIM:146550 and RO:0004003 HGNC:55085 both match). The report's atrichia-with-papular-lesions and hairless-mouse coding-mutant content was deliberately excluded from the mechanism and kept only as a labelled differential diagnosis. Claims dropped or left unevidenced. The topical-minoxidil lead (Cui et al., DOI:10.1111/jocd.70382, PMC12340736) is curated as a treatment with NO evidence item: the record has no abstract in PubMed, Europe PMC or Crossref and no PubMed record at all, so no exact snippet exists. Rather than quote its title as a finding, the limitation is stated in the treatment notes and the paper is listed in the top-level references block. Follicular hyperkeratosis with milia-like papules was not curated because no cached source stated it quotably. No Orphanet evidence could be curated: ORPHA:444 is not in the Orphadata leaf-disorder bulk file this repo caches, so just fetch-reference ORPHA:444 failed and prevalence is curated as measure_type UNKNOWN / prevalence_class RARE with no rate. No conforms_to target was added; there is no hair-follicle-cycle module in kb/modules/, and eda_edar_nfkb_ectodermal_appendage and keratin_intermediate_filament_fragility were inspected and rejected as out of scope. Validation run to completion. just validate, just validate-terms, just count-verified-snippets (71/71 verified), just check-duplicate-keys, just check-entity-refs, just check-causal-targets, just check-qualifier-terms, just check-enum-values, just check-title-snippets, just check-snippet-length, just check-snippet-grading, just check-folded-hyphens, just check-environmental-evidence, just check-not4curation, just check-reference-titles, just normalize-cache, just check-term-cache-integrity - all pass. just validate-disorders kb/disorders/Hypotrichosis_4.yaml: schema 'No issues found', terms 'Validation passed', references 'All validations passed', 'Snippets checked: 71/71 verified against cached references'. just qc was NOT run (exceeds the tool timeout); the individual gates were run instead.

Claude Code ▸
Hypotrichosis 4 (HYPT4 / Marie Unna Hereditary Hypotrichosis 1) — Research Report
claude-haiku-4-5-20251001, claude-sonnet-5 26 citations 2026-09-07T22:12:40.955537

Hypotrichosis 4 (HYPT4 / Marie Unna Hereditary Hypotrichosis 1) — Research Report

0. Identity and Naming Disambiguation (read first)

"Hypotrichosis 4" (HYPT4, OMIM #146550) is the numbered-series name for Marie Unna Hereditary Hypotrichosis 1 (MUHH1), first clinically described by Marie and Unna in a German family in 1925 [Nature Genetics 41:228–233, PMID:19122663]. It is not the same disease as the LIPH-related or LPAR6-related autosomal-recessive woolly-hair/hypotrichosis entries that also carry "Hypotrichosis N" numbers in OMIM's series (those are clinically and genetically distinct recessive disorders with kinky/woolly rather than wiry hair). Within the same clinical entity, there is locus heterogeneity: MUHH1 (HYPT4, chromosome 8p21.3, gene HRURF/historically "U2HR") is the classic and most common form; a second, minor form, MUHH2 (HYPT5, OMIM #612841), is caused by heterozygous missense mutation in EPS8L3 (chromosome 1p13.3) in a single reported Chinese family [escholarship.org/uc/item/6pf0m22z; PMID:24236410]. This report focuses on HYPT4/MUHH1 as specified by MONDO:0100522, and flags MUHH2 only as a lump/split-relevant sibling locus — subsequent sequencing studies in other MUHH families found no EPS8L3 mutations, indicating it is a minor/rare cause [PMID:24236410].

Key identifiers: - OMIM: #146550 (HYPOTRICHOSIS 4; HYPT4) — omim.org/entry/146550 - Gene/locus: HRURF (HR Upstream Reading Frame; formerly designated U2HR), OMIM gene entry *619257, HGNC:55085, chromosome 8p21.3, embedded in the 5′-untranslated region of the HR gene (HR Lysine Demethylase and Nuclear Receptor Corepressor, OMIM *602302, HGNC:5172) - Orphanet: ORPHA444 — orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&Expert=444 - MONDO: MONDO:0100522 (as specified in the target; note MONDO:0007806 appeared adjacent in search results and should be checked for obsolescence/merge status against the current MONDO release before binding) - Synonyms: Marie Unna Hereditary Hypotrichosis 1 (MUHH1); Marie Unna Congenital Hypotrichosis; Hypotrichosis Congenita - Inheritance: Autosomal dominant, full penetrance with variable expressivity (see §9)


1. Disease Information

MUHH1/HYPT4 is a rare autosomal dominant hair disorder with a distinctive triphasic natural history: absent or sparse hair at birth, replaced in infancy/childhood by coarse, wiry, unruly scalp hair, followed by progressive patterned hair loss beginning around puberty that can proceed to near-total alopecia in adulthood [Orphanet ORPHA444; PMID:19122663]. Eyebrows, eyelashes, and body/pubic/axillary/beard hair are sparse to absent from early life onward, distinguishing it from isolated androgenetic alopecia [Orphanet ORPHA444].

Approximately 30 families and sporadic cases with a molecular diagnosis have been reported in the literature to date [Orphanet ORPHA444], spanning German (the original 1925 kindred, molecularly resolved by PMID:20659777), Chinese [PMID:26269244], Turkish, and other ethnic backgrounds — indicating the disorder is panethnic rather than population-restricted.

All information below is derived from aggregated disease-level resources (OMIM, Orphanet, GeneReviews-style literature reviews) and case series/family reports in the primary literature — there is no large EHR/registry cohort for this rare Mendelian disorder.


2. Etiology

Disease Causal Factors

HYPT4 is a purely genetic (monogenic, Mendelian) disorder. There is no established environmental, infectious, or acquired contributing mechanism — the phenotype is present from birth and driven entirely by a cis-regulatory germline mutation (see §4, §6).

Genetic Risk Factors

  • Causal: Heterozygous loss-of-function mutations in HRURF/U2HR, a small inhibitory upstream open reading frame (uORF) located in the 5′-UTR of the HR transcript [PMID:19122663]. Every reported mutation is a gain-of-function at the level of HR protein output achieved through loss of function of the inhibitory uORF peptide — see §4/§6 for the precise mechanism.
  • No susceptibility loci, polygenic risk, or modifier-gene data are available for HYPT4; the disorder behaves as a fully penetrant single-gene trait.
  • Locus heterogeneity: a minority of MUHH families instead carry EPS8L3 mutations (MUHH2/HYPT5, OMIM #612841) [PMID:24236410] — genetically distinct but phenotypically overlapping.

Environmental Risk Factors

None established. Age and sex are not risk-modifying (both sexes affected equally per Orphanet); disease onset (birth/infancy) precedes any plausible environmental exposure window.

Protective Factors

None reported in the genetic or environmental literature. No protective variant or exposure has been described for this gene.

Gene-Environment Interactions

None reported. The disorder's fully penetrant, congenital-onset Mendelian pattern leaves little described room for environmental modulation of penetrance, though the well-documented variable expressivity between and within families (see §9) suggests unidentified modifiers (genetic or environmental) affect severity — this is an open question, not something directly evidenced.


3. Phenotypes

Phenotype Type Onset Frequency Suggested HPO term
Sparse/absent scalp hair at birth Physical sign Congenital Nearly universal HP:0008070 (Sparse hair) — verify against HPO browser before binding
Coarse, wiry, unruly scalp hair in childhood Physical sign/hair-shaft abnormality Infancy–childhood Nearly universal (defining feature) Candidate: "Coarse hair" (HP term exists in the Abnormality of hair texture branch — verify exact CURIE via OAK before curation)
Progressive patterned scalp hair loss Physical sign, progressive Onset at/after puberty Nearly universal, progresses with age HP:0002293 (Hypotrichosis) or a more specific "progressive alopecia" descriptor — verify
Sparse/absent eyebrows Physical sign Congenital/infancy All affected individuals per Orphanet Candidate "Sparse eyebrow" term — verify CURIE
Sparse/absent eyelashes Physical sign Congenital/infancy All affected individuals per Orphanet Candidate "Sparse eyelashes" term — verify CURIE
Sparse/absent body, axillary, pubic, beard hair Physical sign Peripubertal All affected individuals per Orphanet Related to HP:0002215 (Sparse axillary hair) family of terms — verify per-site CURIEs
Follicular hyperkeratosis with milia-like facial papules Physical sign/histopathologic finding Variable, often childhood–adulthood Reported in a substantial minority; not universal Candidate keratosis-pilaris-adjacent HP term — verify; this is a distinguishing feature from simple androgenetic alopecia
Hair shaft abnormalities: increased/variable diameter (up to 0.12 mm), twisting, bending at odd angles, longitudinal grooving, cuticle peeling (on SEM) Laboratory/microscopic finding Present once hair grows in (childhood onward) Consistently described across case series Relates to "Pili torti"/hair-shaft-abnormality branch of HPO — a specific match should be confirmed rather than assumed

Characteristics: - Age of onset: Congenital (present from birth) — the sparse-hair phase is neonatal; the wiry-hair phase is early childhood; progressive loss begins peripubertally. - Severity: Variable — ranges from a fringe of tonsorial-pattern hair remaining in adulthood to near-total scalp alopecia; eyebrow/eyelash/body-hair sparseness is comparatively more uniform in severity across patients. - Progression: Progressive after puberty; scalp involvement typically worsens with age, described as advancing "until only a sparse fringe in the tonsorial distribution remains" [Orphanet ORPHA444]. - Frequency: Core triad (sparse birth hair → wiry childhood hair → progressive scalp loss with sparse eyebrows/eyelashes/body hair) is present in essentially all molecularly confirmed cases; follicular hyperkeratosis/milia-like papules are a variable, not universal, accessory feature [PMC4212298].

Quality of life impact: No disease-specific EQ-5D/SF-36 data were found in the literature searched. The condition is not associated with reduced survival, systemic organ involvement, or intellectual disability — QoL impact is inferred to be primarily psychosocial/cosmetic (a lifelong, progressive, visible hair disorder from birth), consistent with general literature on congenital hypotrichoses, but this inference is not directly sourced to a validated QoL instrument study in HYPT4 specifically.


4. Genetic/Molecular Information

Causal Gene

  • HRURF (previously annotated as U2HR, "upstream open reading frame 2 of HR"), OMIM gene *619257, HGNC:55085, chromosome 8p21.3. Located within the 5′-UTR of the HR gene transcript.
  • The disease-causing gene was mapped to 8p21 by linkage in 2000 [Lefèvre et al., Eur J Hum Genet, PMID:10854110, LOD 8.26 at D8S1786], refined to a 1.1-cM interval in 2004 [PMID:15149494], and the causal gene was identified in 2009 when Wen et al. showed that the pathogenic mutations lay not in the HR coding sequence itself (previously excluded) but in a small inhibitory upstream ORF (uORF) overlapping the HR 5′-UTR [Nat Genet, PMID:19122663].

Pathogenic Variants

  • Affected gene/product: U2HR/HRURF is predicted to encode a highly conserved 34–amino acid peptide (not the HR protein itself) [PMID:19122663].
  • Variant classes reported: loss-of-initiation-codon mutations, delayed/read-through termination-codon mutations, nonsense mutations, and missense mutations within the small uORF — all of which converge functionally on loss of the uORF's translational-repressor activity [PMID:19122663; search summary of subsequent Chinese/Turkish family reports].
  • Functional consequence: These are gain-of-function mutations at the level of downstream HR protein expression — loss of the inhibitory uORF removes translational repression of the main HR open reading frame, resulting in increased HR protein levels, i.e., a dose-sensitivity ("just right" amount of HR corepressor) mechanism rather than classic HR loss-of-function (contrast with atrichia with papular lesions/alopecia universalis congenita, caused by biallelic HR coding loss-of-function — see §6, §14).
  • Origin: Germline, autosomal dominant; recurrent/founder-like variants have been reported across multiple ethnically distinct families (German original-1925 kindred [PMID:20659777], Chinese families [PMID:26269244], and others), consistent with mutational hotspots within this small uORF rather than a single global founder haplotype.
  • Allele frequency: No population allele-frequency data (gnomAD, etc.) were retrieved for specific HRURF pathogenic alleles in this search; given the rarity of the disease (~30 molecularly confirmed families worldwide) and dominant fully penetrant inheritance, pathogenic alleles would be expected to be absent or vanishingly rare in population reference databases — this should be confirmed per-variant in gnomAD before curation rather than assumed.

Modifier Genes

None established. The variable expressivity of scalp-loss severity between affected relatives carrying the same mutation (see §9) implies unidentified modifiers, but no specific modifier gene has been reported.

Epigenetic Information

No disease-specific DNA methylation, histone modification, or chromatin studies in HYPT4 patient tissue were identified in this search. Mechanistically, the downstream consequence of the mutation (increased HR corepressor levels) itself alters chromatin state at nuclear-receptor target genes via HR's histone-deacetylase-recruiting corepressor activity (see §6) — this is a molecular mechanism, not a patient-epigenome finding.

Chromosomal Abnormalities

None reported; HYPT4 is caused by point/small-indel mutations, not by large structural chromosomal rearrangements.


5. Environmental Information

No environmental factors, lifestyle factors, or infectious agents have been implicated as causal or modifying for HYPT4 in the literature searched. This is consistent with its status as a fully penetrant monogenic disorder with congenital onset.


6. Mechanism / Pathophysiology

Causal chain (ordered)

  1. A heterozygous germline mutation disrupts the small inhibitory upstream open reading frame (U2HR/HRURF) in the 5′-UTR of the HR transcript — loss of the initiation codon, a delayed/read-through termination codon, or a nonsense/missense change within the 34-aa uORF peptide [PMID:19122663]. (Molecular lesion.)
  2. This leads to loss of the uORF peptide's normal translational-repressor function on the downstream, in-frame main HR ORF — ribosomes that would normally stall/re-initiate poorly after translating the short uORF instead proceed efficiently to translate full-length HR protein [PMID:19122663]. (Directly demonstrated — the founding paper shows increased HR expression from mutant uORF constructs.)
  3. This results in increased steady-state levels of the HR protein — HR Lysine Demethylase and Nuclear Receptor Corepressor — in hair-follicle keratinocytes and other HR-expressing tissue [PMID:19122663; genesdev.cshlp.org/content/15/20/2687].
  4. Excess HR protein leads to exaggerated corepressor activity at nuclear-receptor target genes. HR is a nuclear-localized transcriptional corepressor that binds directly to the vitamin D receptor (VDR), and also represses thyroid hormone receptor (TR) and retinoic-acid-receptor-related orphan receptor-α (RORα), by recruiting histone deacetylases (HDACs) and by intrinsic histone-demethylase activity, driving chromatin remodeling that silences VDR/TR/RORα target genes [PMID:12847098 (Physical and functional interaction between VDR and hairless corepressor); Endocrinology 150:4950 (isoform-specific VDR modulation); genesdev.cshlp.org/content/15/20/2687]. (Demonstrated in cell/biochemical and mouse systems — an inference step when extrapolated to the specific human HYPT4 hair follicle, i.e., indirect evidence for the human disease mechanism.)
  5. Excessive/dysregulated repression of VDR/TR/RORα target-gene transcription disrupts the normal transcriptional program that HR and VDR jointly execute during the catagen-to-telogen and telogen-to-anagen transitions of the postnatal hair cycle — both HR loss-of-function and VDR loss-of-function independently cause total alopecia in mice and humans, establishing that correctly dosed HR/VDR corepressor activity, not simply "more or less," is required for normal cycling [PMID:12847098; Sci Rep, "Molecular evolution of HR", PMC3216519]. (This step is inferred from parallel HR/VDR loss-of-function biology; direct demonstration that HR gain-of-function specifically disrupts this transition in human MUHH1 follicles has not been shown at the molecular level — flagged as inferred rather than demonstrated in patients.)
  6. Failure of the hair follicle to complete normal cycling manifests clinically as an unstable, progressively degenerating follicular program: normal follicles at birth transiently produce structurally abnormal (coarse, twisted, variable-diameter) hair shafts in childhood, and then, beginning at puberty (a period of major systemic hormonal/nuclear-receptor signaling change), follicles progressively fail to re-enter productive anagen, causing patterned, progressive alopecia together with sparse eyebrows/eyelashes/body hair [Orphanet ORPHA444; PMID:19122663]. (Clinical manifestation — directly observed; the precise cellular step at which follicles fail, e.g., stem-cell-niche exhaustion vs. premature catagen entry, has not been isolated in human tissue in the sources reviewed.)
  7. Branch — accessory/variable feature: in a subset of patients, disordered follicular keratinization also produces follicular hyperkeratosis with milia-like facial papules, histologically distinct from classic keratosis pilaris (which shows epidermal hyperkeratosis/hypergranulosis/follicular plugging from a different, non-HR-driven process) [PMC4212298; comparison search]. The mechanistic link from HR dosage to this keratinization phenotype specifically is not detailed in the sources reviewed and should be treated as an open question rather than an established step in the chain.

Molecular pathways

The operative pathway is nuclear-receptor corepressor signaling: HR–VDR, HR–TR (thyroid hormone receptor), and HR–RORα axes, converging on HDAC recruitment and chromatin remodeling at target promoters controlling the hair cycle [PMID:12847098; genesdev.cshlp.org/content/15/20/2687]. Suggested GO terms: GO:0003714 (transcription corepressor activity); GO:0070577 (lysine-histone demethylase activity, if using HR's demethylase function); GO:0042633 (hair cycle) — verify exact CURIEs before binding.

Cellular processes

Disrupted terminal differentiation/keratinization program of the hair follicle outer root sheath and matrix keratinocytes; disrupted hair-cycle-phase transitioning (anagen–catagen–telogen). No apoptosis, autophagy, or classic inflammatory-cascade mechanism is centrally implicated by the sources reviewed, though mild inflammatory infiltrate around reduced follicle numbers has been noted histologically [search: histopathology summary].

Protein dysfunction

This is fundamentally a dosage/gain-of-expression disorder rather than a structural protein-misfolding disorder: the mutant uORF peptide loses its own inhibitory function, and the downstream consequence is excess of an otherwise wild-type HR protein, not a structurally altered HR protein. This is mechanistically distinct from HR-coding-region loss-of-function mutations that cause atrichia with papular lesions/alopecia universalis congenita (§14).

Metabolic changes

None specifically reported for HYPT4.

Immune system involvement

Not centrally implicated; mild perifollicular inflammatory infiltrate has been described histologically but is not characterized as a primary immune-mediated mechanism [search: histopathology summary; PMC4212298 for full histopathology detail — should be read directly before asserting further specifics].

Tissue damage mechanisms

Progressive follicular miniaturization/loss with reduced follicle density; no fibrosis or scarring is described, consistent with a non-scarring alopecia [search: histopathology summary].

Biochemical abnormalities

Increased HR corepressor protein dosage (see causal chain step 3) is the core molecular lesion; no enzyme-deficiency or ion-channel-defect mechanism applies here.

Molecular profiling / advanced technologies

No transcriptomic, proteomic, metabolomic, lipidomic, single-cell, or spatial-transcriptomic datasets specific to HYPT4 patient hair follicles were identified in this search (GEO/ArrayExpress/Human Cell Atlas were not directly queried with disease-specific hits returned). This is a gap — human hair-follicle multi-omic characterization of HYPT4 has apparently not been published, or was not surfaced by this search; this should be explicitly stated as absent evidence, not silently omitted, in any downstream curation.

Suggested cell types (CL) and anatomical terms (UBERON): hair follicle outer root sheath cell, hair matrix keratinocyte, hair follicle dermal papilla cell — exact CL CURIEs should be selected and verified via OAK rather than guessed here.


7. Anatomical Structures Affected

  • Organ level: Primary — skin/integumentary system, specifically the pilosebaceous unit (hair follicles) of the scalp, eyebrows, eyelashes, and body/pubic/axillary/beard sites. No other organ system involvement is reported for HYPT4 (contrast with some HR-coding mutations, which have been associated in isolated case reports with additional findings — see §14 caveat).
  • Tissue/cell level: Hair follicle epithelium (outer root sheath, matrix), hair shaft cuticle/cortex (structurally abnormal — twisted, variable-diameter, grooved shafts visible by SEM) [search: histopathology summary].
  • Subcellular level: Nuclear — HR protein and its VDR/TR/RORα corepressor complexes act in the nucleus of follicular keratinocytes; relevant GO Cellular Component term candidates include GO:0005634 (nucleus) and a nuclear-receptor-corepressor-complex term — verify exact CURIE.
  • Localization: Diffuse across scalp, eyebrows, eyelashes, and body-hair-bearing skin; scalp involvement is patterned (tonsorial-distribution-sparing in advanced disease, similar in distribution to androgenetic alopecia) [Orphanet ORPHA444]. Bilateral/symmetric, not lateralized.

8. Temporal Development

  • Onset: Congenital — sparse/absent hair present at birth. Onset of the coarse-wiry-hair phase is early infancy/childhood. Onset of progressive hair loss is peripubertal.
  • Onset pattern: Insidious/progressive rather than acute, across three sequential clinical phases (sparse at birth → coarse in childhood → progressive loss from puberty).
  • Progression: Continuous, generally worsening with age into adulthood; not staged by a formal clinical staging system in the sources reviewed. Progression rate is described qualitatively as gradual, with severity plateauing to "a sparse fringe in the tonsorial distribution" in the most advanced cases rather than complete universal alopecia [Orphanet ORPHA444].
  • Course pattern: Progressive, not episodic or relapsing-remitting; no spontaneous remission is described.
  • Duration: Chronic and lifelong — no reported spontaneous resolution.
  • Critical periods: Puberty is repeatedly identified across sources as the key inflection point for onset of hair loss, plausibly reflecting interaction with the pubertal hormonal/nuclear-receptor signaling milieu acting on an already HR-dysregulated follicle — this link is suggested by the coincidence of timing across the literature but is not mechanistically proven in the sources reviewed.

9. Inheritance and Population

Epidemiology

  • Prevalence/incidence: Unknown/not formally estimated; Orphanet explicitly states prevalence and incidence are unknown, with "approximately 30 families and sporadic cases" molecularly reported worldwide [Orphanet ORPHA444]. This should be curated as prevalence_class: NOT_YET_DOCUMENTED with measure_type: CASES_IN_LITERATURE per the dismech prevalence-modeling convention, rather than assigning a numeric rate.

Inheritance

  • Pattern: Autosomal dominant [OMIM #146550; Orphanet ORPHA444].
  • Penetrance: Described in the literature as effectively complete (all mutation carriers manifest some degree of the phenotype), though this report did not retrieve a formal penetrance-percentage study; this should be verified against GeneReviews/ClinGen-style sources before asserting "complete" with high confidence.
  • Expressivity: Variable — severity of scalp hair loss (from a mild receding pattern to near-total alopecia) differs between and within affected families carrying comparable mutations [general theme across case reports, e.g., PMC12646977, PMC4212298].
  • Genetic anticipation: Not reported.
  • Germline mosaicism: Not specifically reported for this gene, though the diversity of independently arising uORF mutations across families suggests standard germline transmission rather than a single ancestral mutation being propagated by mosaicism.
  • Founder effects: No single global founder mutation has been established; distinct pathogenic uORF variants have been independently identified in German, Chinese, and Turkish (among other) families, consistent with a hotspot-mutable small regulatory element rather than one founder haplotype [PMID:20659777; PMID:26269244].
  • Consanguinity: Not a relevant risk factor for this autosomal dominant disorder (in contrast to the recessive LIPH/LPAR6 hypotrichoses).
  • Carrier frequency: Not applicable in the classic sense (dominant, not silent-carrier disease); no population carrier-frequency data located.

Population demographics

  • Affected populations: Reported across multiple ethnic backgrounds (German, Chinese, Turkish, and others per Orphanet's "various ethnic backgrounds" note) — no population enrichment identified.
  • Geographic distribution: No endemic or regionally clustered distribution reported; cases are globally sporadic/familial.
  • Sex ratio: Reported as affecting both sexes, without a stated skew (autosomal, non-sex-linked inheritance is consistent with this).
  • Age distribution: All affected individuals are, by definition, affected from birth; clinical presentation/severity distribution shifts with age due to the three-phase natural history (see §8).

10. Diagnostics

Clinical tests

  • Laboratory tests: No disease-specific biochemical or enzymatic assay exists; routine labs are not diagnostic.
  • Biomarkers: None established.
  • Imaging: Not routinely used; not a structural/organ-imaging diagnosis.
  • Biopsy/histopathology: Scalp biopsy can show reduced follicle numbers with mild-to-moderate inflammatory infiltrate, without fibrosis or scarring, sometimes with diffuse follicular hyperkeratosis and milia-like facial lesions [PMC4212298; search summary]. Hair shaft microscopy/SEM is diagnostically supportive: shafts of increased and variable diameter (up to 0.12 mm), deeply pigmented, twisted, bent at odd angles, with longitudinal grooving and cuticle peeling [search: clinical-features summary; PMC4212298 for the full large-pedigree description].

Genetic testing

  • Recommended approach: Molecular confirmation via sequencing of the small HRURF/U2HR uORF region in the HR 5′-UTR — a single-gene/targeted-region test given the small size of the causal element, though it may be captured incidentally on hair-loss/ectodermal-dysplasia gene panels or WES/WGS depending on annotation of this UTR-embedded ORF (note: because HRURF is a small uORF and only relatively recently (2009) recognized as a distinct causal element, older HR-only coding-sequence panels/tests would miss these mutations — a clinically important pitfall) [PMID:19122663].
  • WES/WGS utility: Useful if the HRURF uORF region is specifically annotated/captured; historically several "novel loci"/negative-sequencing reports in MUHH families reflect exactly this annotation gap (e.g., a WES study reporting "a novel loci of the HR gene," IJDVL) — should be read directly for detail before citing further.
  • Single-gene testing: HRURF uORF sequencing is the direct confirmatory test once MUHH1 is clinically suspected.
  • CMA/karyotype/FISH/mitochondrial/repeat-expansion testing: Not applicable — this is a small point-mutation/indel disorder in a discrete non-coding regulatory element, not a structural, mitochondrial, or repeat-expansion disease.

Omics-based diagnostics

Not part of routine or reported diagnostic practice for this disorder based on the sources reviewed.

Clinical criteria

No formal DSM/ICD/society-published diagnostic-criteria checklist was identified; diagnosis rests on the characteristic triphasic clinical history (sparse birth hair → coarse childhood hair → progressive peripubertal loss) plus family history consistent with autosomal dominant inheritance, supported by hair-shaft microscopy and confirmed by HRURF sequencing.

Differential diagnosis (distinguishing features): - Atrichia with papular lesions / Alopecia universalis congenita (biallelic HR coding loss-of-function; autosomal recessive; complete, permanent, non-regrowing alopecia from infancy without the intervening coarse-hair phase) [genesdev.cshlp.org/content/15/20/2687]. - Autosomal recessive woolly hair/hypotrichosis (LIPH, LPAR6/P2RY5, KRT25, C3ORF52 — recessive, kinky/woolly rather than wiry hair) [search: LIPH summary]. - Keratosis pilaris / keratosis pilaris atrophicans faciei (distinct histology: epidermal hyperkeratosis/hypergranulosis/follicular plugging without the hair-density/hair-shaft phenotype of HYPT4) [search: KP comparison]. - MUHH2/HYPT5 (EPS8L3-related; phenotypically similar but genetically distinct — OMIM #612841) [PMID:24236410]. - Androgenetic alopecia (much later onset, no congenital sparse-hair or coarse-wiry-hair phase, no eyebrow/eyelash involvement).

Screening

No population or newborn screening program exists for this ultra-rare dominant disorder; case-finding is via clinical recognition and, once a family mutation is known, cascade testing of at-risk relatives is appropriate (standard practice for a dominant Mendelian trait, though not explicitly documented in the sources reviewed as a formal cascade-screening protocol for this specific gene).


11. Outcome/Prognosis

  • Survival/mortality: Not a life-limiting condition; no mortality or reduced-life-expectancy data are relevant, as HYPT4 has no reported systemic/visceral organ involvement.
  • Morbidity/function: Purely a hair/integumentary phenotype; no functional organ impairment reported. Presumed psychosocial/cosmetic morbidity given the visible, progressive, lifelong nature of the condition, though no disease-specific QoL instrument study was located in this search (flagged as absent evidence, not asserted).
  • Complications: Follicular hyperkeratosis/milia-like facial papules in a subset of patients (§3) is the main reported "complication"-adjacent finding beyond the core hair phenotype; no infections, organ failure, or other systemic complications reported.
  • Recovery potential: The natural course is progressive rather than self-limited; treatment (§12) can partially restore hair density/regrowth in some patients but does not reverse the underlying follicular dysregulation, and effects are reported to be treatment-dependent (regrowth plateaus/reverses on discontinuation of topical minoxidil in the one reported pediatric case) [PMC12340736].
  • Prognostic factors: No formal prognostic-biomarker or severity-predictor study was identified; clinical severity appears to vary by family/individual (variable expressivity, §9) without an established predictor.

12. Treatment

Current status: no disease-modifying or targeted (mutation-correcting) therapy exists; management is symptomatic [search: treatment summary].

Pharmacotherapy

  • Topical minoxidil 5%: The best-documented intervention. A 2025 case report describes a 4-year-old girl with a recurrent HRURF variant treated with once-daily 5% topical minoxidil, achieving significant scalp hair density/regrowth improvement by 12 weeks, further improvement at 6 months, with regression on discontinuation and resumption of growth on restarting — supporting a maintenance-dependent pharmacologic effect rather than a cure [J Cosmet Dermatol 2025, PMID pending confirmation via PMC12340736 — DOI: 10.1111/jocd.70382]. Proposed mechanism: minoxidil promotes anagen entry and prolongs follicular activity, plausibly counteracting the disrupted hair-cycle transition described in §6, though this is inferred general minoxidil pharmacology rather than a mechanism proven specific to HR-corepressor dysregulation. NCIT candidate term: NCIT:C15986 (Pharmacotherapy) as treatment_term, with therapeutic_agent bound to minoxidil (CHEBI term — verify exact CURIE).
  • No other pharmacologic agent has published efficacy data for HYPT4 specifically in the sources reviewed.
  • Pharmacogenomics: Not applicable/not studied for this disorder.

Advanced therapeutics

Gene therapy, cell therapy, RNA-based therapy, targeted molecular therapy, and immunotherapy have not been reported or trialed for HYPT4 in the literature searched — the small-uORF, gain-of-repressor-dosage mechanism is in principle an attractive target for future antisense/uORF-modulating approaches, but no such published work was found; this should be stated as an evidence gap rather than a therapeutic option.

Surgical/interventional

  • Hair transplantation: Discussed in general hypotrichosis-management literature as showing "the most promise for localized forms" but success is described as variable and dependent on remaining donor-follicle density, without HYPT4-specific outcome data located in this search [search: treatment summary].

Supportive/rehabilitative

No disease-specific supportive-care, physical therapy, or rehabilitation literature applies (non-functional, cosmetic/dermatologic condition). Psychosocial/cosmetic counseling is a reasonable inferred supportive measure but is not specifically documented in a HYPT4 source.

Experimental

No registered clinical trials (ClinicalTrials.gov / WHO ICTRP) specific to HYPT4/MUHH1 were identified in this search.

Treatment outcomes

  • Response rates: Limited to the single detailed pediatric minoxidil case report cited above; no larger case series with quantified response rates was found.
  • Adverse events: The minoxidil case reported no irritation or hypertrichosis at 5% topical dosing in that patient [PMC12340736]; general minoxidil adverse-event profile (irritant contact dermatitis, unwanted facial hypertrichosis) applies generically but was not specifically documented as occurring in HYPT4 patients in the sources reviewed.

Treatment strategy

No published treatment algorithm/guideline specific to HYPT4 exists; management is empiric and individualized, with topical minoxidil as the most evidence-supported current first-line symptomatic option and lifelong dermatologic follow-up recommended given the progressive natural history [search: treatment summary].


13. Prevention

  • Primary prevention: Not applicable in the population-health sense (monogenic dominant disorder; no modifiable risk-factor-based primary prevention exists). The only "primary prevention" concept applicable is reproductive/genetic counseling for known mutation carriers regarding the 50% transmission risk to offspring given autosomal dominant inheritance.
  • Secondary prevention: No early-detection screening program exists; early clinical recognition (sparse birth hair progressing to coarse childhood hair) allows earlier initiation of symptomatic management (e.g., minoxidil) before extensive hair loss, which is a plausible but not formally studied secondary-prevention rationale.
  • Tertiary prevention: Ongoing dermatologic monitoring and symptomatic treatment (§12) to limit progression-related cosmetic morbidity.
  • Immunization: Not applicable.
  • Genetic screening: Prenatal diagnosis or preimplantation genetic diagnosis has not been specifically reported for this condition in the sources reviewed, though it would be technically feasible once a family's causal HRURF variant is known (standard for any characterized autosomal dominant Mendelian disorder) — this is an inference, not a documented practice.
  • Genetic counseling: Appropriate and presumably standard of care given full penetrance and 50% transmission risk, though no HYPT4-specific counseling-outcomes literature was located.
  • Public health/environmental/prophylaxis: Not applicable — no environmental or infectious contributor exists to intervene upon (§5).

14. Other Species / Natural Disease

  • Taxonomy: The principal comparative/model system is mouse (Mus musculus, NCBITaxon:10090).
  • Orthologous gene: Mouse Hr (hairless) — the murine ortholog of human HR; the Hr mutation was first recognized in mice ~75 years before the human gene was cloned, originally arising from an endogenous retroviral insertion [RIKEN BRC mouse-of-the-month summary]. Note: the specific HRURF/U2HR uORF-level gain-of-repressor-dosage mechanism causing human MUHH1 is a distinctly human (or at least separately characterized) regulatory mechanism — the classic mouse hr/hr^rh (rhino) models are coding-region loss-of-function models, mechanistically analogous to human recessive HR-null disease (atrichia with papular lesions / alopecia universalis congenita, see below), not to the dominant uORF gain-of-function mechanism of HYPT4 itself. This distinction is important and should not be blurred in curation.
  • Natural/veterinary disease: The classic hairless (hr) and rhino (hr^rh) mouse strains are naturally arising/ENU-induced coding mutants, not spontaneous companion-animal disease reports; homozygous mutant mice are born with normal skin/follicles but become completely naked within four weeks and develop skin and nail anomalies, and are widely used as a dermatology research tool strain precisely because of this phenotype [RIKEN BRC; ScienceDirect Hairless Mouse overview]. No OMIA (naturally occurring companion-animal) entry specific to a HRURF-uORF-analogous dominant disorder was identified in this search.
  • Comparative biology: HR functions as a nuclear receptor corepressor (of TR, RORα, VDR) in both mouse and human, and Hr/HR is evolutionarily conserved in its role regulating the postnatal hair cycle [Sci Rep, "Molecular evolution of HR", PMC3216519]. The progression of the human congenital HR-coding disorders (atrichia with papular lesions, alopecia universalis congenita) closely parallels the hairless-mouse phenotype, establishing strong cross-species conservation of HR's hair-cycle role at the loss-of-function end of the allelic spectrum — the human MUHH1/HYPT4 gain-of-repressor-dosage phenotype is the human-specific, milder, dominant end of that same gene's allelic spectrum.
  • Transmission: Not applicable — non-infectious, non-zoonotic monogenic disorder.

15. Model Organisms

  • Model type: Genetic (naturally arising and induced) mouse models exist for the HR gene broadly, but no mouse model specifically recapitulating the HRURF/U2HR uORF dominant gain-of-function mechanism of HYPT4/MUHH1 was identified in this search — this is a notable gap given how mechanistically specific (uORF-level dosage control) the human disease mutation class is.
  • Specific model systems available (for the broader HR locus):
  • Hairless (hr) mouse: classic naturally arising coding-loss-of-function mutant (originally a retroviral insertion) [RIKEN BRC].
  • Rhino (hr^rh) mouse: allelic Hr coding mutant with a related but distinct phenotype [ScienceDirect Hairless Mouse overview].
  • Hr^m1Enu mouse: an ENU-induced novel missense Hr mutant causing irreversible hair loss, characterized genetically and molecularly [ScienceDirect, PMID search: "A novel missense mutation in the mouse hairless gene causes irreversible hair loss"].
  • Induced models: The ENU mutagenesis-derived Hr^m1Enu allele is the clearest "induced" (as opposed to spontaneous) Hr model identified.
  • Genetic model types available: Naturally arising and ENU-induced point/insertional coding mutants exist; no conditional, humanized, or uORF-specific knock-in model for the HRURF dominant mechanism was located.
  • Phenotype recapitulation: The existing Hr-coding mouse models recapitulate the recessive, complete-alopecia end of the human HR-related disease spectrum (analogous to atrichia with papular lesions/alopecia universalis congenita) well — "the progression of the human disorders atrichia with papular lesions and alopecia universalis congenita is very similar to that of the hairless mouse" [search: mouse-model summary]. They do not model the dominant, dosage-sensitive, triphasic (sparse→coarse→progressive-loss) HYPT4/MUHH1 phenotype, which is mechanistically a gain of HR corepressor dosage rather than its loss.
  • Model limitations: The absence of a uORF-specific dosage model for HYPT4 is itself the principal limitation — inference about the human dominant disease mechanism currently rests on (a) in vitro translation/reporter assays of the mutant uORF [PMID:19122663] and (b) parallel HR/VDR biochemical corepressor studies performed in cell lines and in the (loss-of-function) mouse models, not on a disease-matched in vivo gain-of-function model.
  • Research applications: The existing Hr mouse models are broadly used for skin/dermatology research generally (their naked phenotype is convenient for topical/dermatologic testing without shaving), but their specific research applicability to HYPT4/MUHH1 mechanism is indirect (informs HR/VDR/TR corepressor biology generally, not the dominant uORF-dosage mechanism specifically).
  • Resources: MGI (Mouse Genome Informatics) is the relevant repository for Hr allele records; specific accession numbers for hr, hr^rh, and Hr^m1Enu were not individually retrieved in this search and should be looked up directly in MGI before citing as dismech animal_models entries.

Summary of Key Ontology Term Candidates (verify all before binding)

Concept Suggested term Note
Disease MONDO:0100522 (as given); cross-check MONDO:0007806 for merge/obsolescence OMIM:146550, ORPHA:444
Causal gene hgnc:55085 (HRURF) chr8p21.3
Related HR gene hgnc:5172 (HR) chr8p21.3
MUHH2 sibling locus gene EPS8L3 (HGNC:21297), OMIM #612841 For lump/split note only
Core phenotype HP:0008070 (Sparse hair) Reasonably confident
Hypotrichosis general HP:0002293 (Hypotrichosis) Reasonably confident
Sparse eyebrow/eyelash/body hair Not confidently resolved in this search Must verify exact CURIEs via OAK before curation
Coarse/wiry hair shaft abnormality Not confidently resolved Must verify
Corepressor mechanism GO:0003714 (transcription corepressor activity) Verify
Hair cycle GO:0042633 (hair cycle) Verify
Cell types Hair follicle outer root sheath cell, hair matrix keratinocyte (CL) Verify exact CURIEs
Anatomy Hair follicle, eyebrow, eyelash (UBERON) Verify exact CURIEs
Treatment NCIT:C15986 (Pharmacotherapy) + therapeutic_agent minoxidil (CHEBI, verify)

Sources

Evidence gaps to flag explicitly in curation (per this session's evidence-attribution standard — an acknowledged gap, not a smoothed-over one): (1) no molecular/omics dataset specific to HYPT4 patient hair-follicle tissue was located; (2) no disease-specific quantitative penetrance or QoL-instrument study was located; (3) no HYPT4-matched (uORF-level dominant gain-of-function) animal model exists — all current mouse models represent the mechanistically distinct recessive HR-coding-loss end of the allelic spectrum; (4) several HPO term matches above are stated as candidates only and were not resolved to verified CURIEs in this search — resolve via OAK/HPO browser before any KB curation.

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 14
Resolved 14
Unresolved (possible confabulation) 0
Unverifiable 0
References weighed for topical relevance 14
On topic 10
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 16
Resolved 9
Unresolved (possible confabulation) 0
Obsolete 2
Unverifiable 5
Terms whose name was checked 6
Terms named correctly 5
Terms named as a different term 1

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

  • HP:0002293 (2 mentions) - the report calls it "Hypotrichosis"; HP calls it Alopecia of scalp

Obsolete terms

These terms are real but deprecated. Citing one is not a fabrication; it does mean the report is naming something the ontology has retired:

  • MONDO:0007806 (obsolete hypotrichosis 4) (2 mentions) - replaced by MONDO:0100522
  • GO:0070577 (obsolete lysine-acetylated histone binding) (1 mention) - replaced by GO:0140566

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: OMIM, ORPHA.